Abstract:

Asymptomatic malaria is prevalent in highly endemic areas of Africa, with only a small percentage of individuals exhibiting clinical symptoms. The clinical consequence of asymptomatic malaria is not fully understood. Some researchers believe that asymptomatic parasitaemia is involved in developing partial immunity and may protect against clinical disease from new infections. This study therefore determined the prevalence of asymptomatic reservoir of plasmodium falciparum and the level of knowledge of malaria among the populace in Nasarawa state. A community-based cross-sectional study was conducted among selected local government areas of the state. The local government areas were observed to have reported the highest positivity rate of malaria between 2017 to 2022. The study was conducted from August 2022 to April 2023. A semi-structured questionnaire was employed to collect socio-demographic data and other associated risk factors by trained health professionals. Body temperature and different clinical manifestations were examined to identify the asymptomatic individuals. This examination was carried out after the selection of individuals from households before mRDT was conducted. Data entry and analysis were carried out using (SPSS, 20). The study indicates that the prevalence of asymptomatic malaria parasitaemia among adults in Nasarawa state is 23.8%. It is evidenced that malaria is endemic in Nasarawa state. This study, therefore, recommends continuous awareness of malaria, control measures, and environmental sanitation to control further transmission of malaria in the state.

References:

Abstract:

Healthcare associated infections (HCAI) remain a global` problem, affecting millions of people worldwide and accounting for prolonged hospitalization and increased financial burden. Establishing infection prevention and control (IPC) programs is effective in reducing the incidence of HCAI, but the status of IPC programs is not well documented in Cameroon. We assessed the core components of IPC programs with a focus on HCAI surveillance in some health facilities using the WHO assessment framework (IPCAF). We carried out a cross-sectional study from October 2019 to January 2021. Health facilities were chosen purposefully. Trained data collectors traveled to health facilities and administered the IPCAF questionnaire to authorities of health facilities. All eight components of an IPC program were assessed. Data collected was analyzed using Statistic Package for Social Sciences (SPSS 27.0) software. Altogether 65 health facilities were assessed, 81.5% of which were public facilities. The median IPCAF score from the health facilities was 275 (Range: 112.5- 595) on a scale of 800, with most (86%) of them having either an inadequate (29%) or a basic (57%) IPC status. None of the health facilities attained the advanced IPC status. HCAI surveillance was the weakest of the eight IPC core components. Most (89.2%) of the health facilities did not include HCAI surveillance in their IPC programs. There is therefore need to strengthen IPC programs in health facilities in Cameroon, with a focus on the surveillance of HCAIs, which was the weakest core component.

References:

Abstract:

This study explored the integration of nutrition care services into the Health Care System in Ntungamo District. The study also described the knowledge and attitude of staff on the integration of Nutrition care services in Public Health facilities, to identify the systems and structures in place for promoting the integration of nutrition care services into Health Care system in Public Health Facilities and to examine the available policies and guidelines on integration of Nutrition care services in Public Health facilities in Uganda, and their utilization in Ntungamo District. It was a cross-sectional descriptive study involving 196 respondents and carried out in one hospital and three HCIVs. Quantitative data was analyzed using SPSS version 16.0 while qualitative data was analyzed using thematic and content analysis. Most of the respondents, 151, (77%), said that some facilities don’t conduct nutrition care community mobilization and sensitization while 45 (23%) of the respondents mentioned that they conduct nutrition care community mobilization and sensitization. It can be concluded that there was minimal integration of Nutrition care services in Public Health facilities in Ntungamo District. It is recommended that the district should increase funding to nutrition activities in the district budget and work plan as well as conduct training to improve on capacity building of all health workers including Doctors and clinical officers.

References:

[1] GAIN. (2012). Global health for improved nutrition. Health Science Journal, 127-136. https://www.google.com/url

[2] WHO. (2017). Integrating Nutrition into Food Security and Livelihoods Interventions for Emergencies. Retrieved April 17, 2018, from http://fscluster.org/sites/default/files/documents/guidelinesintegrating_nutrition_into_food_security.pdf

[3] PATH (2011). Nutrition Care Process and Model Update: Toward Realizing People-Centered Care and Outcomes Management. Journal of academy of nutrition and dietetics, 2003-2014.

[4] National Health Survey (2014). Malnutrition prevalence in south western uganda. Retrieved April 25, 2018, from https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-3156.2010.02476.x

[5] Shaw RH, Tanner R, Djeddour D & Cortat G (2011). Classical biological control of Fallopia japonica in the United Kingdom – lessons for Europe. Weed Research51, 552–558 https://doi.org/10.1111/j.1365-3180.2011.00880.x

[6] Aisha K Yuosafizai, F. A. (2013). Review of implementation process for integrated nutrition and psychosocial stimulation interventions. New york: New york academy of science.

[7] Maleta and Amadi (2017) Community-Based Management of Acute Malnutrition (CMAM) in Sub-Saharan Africa: Case Studies from Ghana, Malawi, and Zambia

[8] Guyon et al (2014). Urban Agriculture Impacts: Social, Health, and Economic: . Retrieved April 14, 2019, from http://asi.ucdavis.edu/programs/sarep/publications/food-and-society/ualitreview-2018.pdf

[9] FANTA. (2017). Multisectoral nutrition programming. Retrieved April 13, 2019, from https://reliefweb.int/sites/reliefweb.int/files/resources/aug_2017-fanta_achievements_lessons_learned.pdf

[10]    USAID. (2011). Multisectoral nutrition strategy. Retrieved April 13, 2018, from https://www.usaid.gov/sites/default/files/documents/1867/USAID_Nutrition_Strategy_5-09_508.pdf

[11]    MOH. (2010). Uganda nutrition action plan-National planning authority. Retrieved April 25, 2018, from http://npa.ug/wp-content/themes/npatheme/documents/nutrition_action_plan.pdf

[12]    Uganda nutrition action plan (UNAP,2011) Scaling Up Multi-Sectoral Efforts to Establish a Strong Nutrition Foundation for Uganda’s Development https://www.google.com/url?

[13]    MOH (2014), HEALTH SECTOR STRATEGIC PLAN III 2010/11-2014/15

[14]    Centers for Disease Control and Prevention (2011) http://apps.nccd.cdc.gov/DDTSTRS/default.aspx

[15]    MAAIF. (2016). Scaling up multi-sectoral efforts to establish strong nutrition foundation for Uganda. Retrieved April 13, 2018, from https://scalingupnutrition.org/wp-content/uploads/2013/02/Uganda_NutritionActionPlan_Nov 2011.pdf

[16]    Kish, L. (1965) Survey sampling. John Wiley and Sons, Inc., New York. https://www.worldcat.org/title/survey-sampling/oclc/256017

[17]    Patton. M. Q. (2002). Qualitative research and evaluation methods (3rd ed.). Thousand Oaks, CA: Sage Publications.

[18]    Esther Suter, M. S. (2017). Indicators and Measurement Tools for Health Systems Integration: A Knowledge Synthesis. International juornal of integrated care, 52-72.

[19]    Evans Janna, A. G. (2014). Organisational context and capabilities for integrating care: A flame work for improvement. International journal of integrated care, 120-134.

Izudi Jonathan, C. (2017). Quality Improvement Interventions for Nutritional Assessment among Pregnant Mothers in Northeastern Uganda. US national library of medicine, 125-145

Abstract:

Viral hepatitis encompasses liver inflammation caused by hepatotropic viruses, including hepatitis A, B, C, D, and E. The global prevalence of hepatitis B infection surpasses 300 million people. Pregnant women are particularly vulnerable to this infection, which significantly impacts maternal and child health. Limited knowledge and inadequate surveillance programs in Nigeria contribute to underestimating the prevalence rate. This study aims to assess the prevalence and knowledge of hepatitis B virus infection among pregnant women attending antenatal care at Federal Teaching Hospital Ido-Ekiti in Ekiti State, Nigeria. A descriptive cross-sectional study design was employed, utilizing a multi-stage sampling technique. Data collection involved self-administered semi-structured questionnaires, and analysis was conducted using IBM SPSS version 27.0. Findings revealed that approximately 69.9% of the study respondents possessed good knowledge regarding hepatitis B infection. The prevalence of hepatitis B infection among respondents was 9.6%. Notable associations were observed between occupation, religion, parity, history of multiple sexual partners, knowledge, and the prevalence of hepatitis B infection. While most respondents exhibited commendable knowledge and surprisingly low prevalence rates within the facility, the government must enhance knowledge dissemination and increase accessibility to vaccinations. The occurrence of chronic liver disease and hepatocellular carcinoma are most time linked to Hepatitis B infection, however, most individuals are not aware of this. This study will help increase awareness of the causes and benefits of early diagnosis and treatment of the infection in other to prevent the life-threatening complications associated with it. It will help reduce the infection through policy and implementation of preventive strategies.

References:

[1] Osler, W., 1921, The evolution of modern medicine. New Haven, USA: Yale University Press, 20–26.

[2] Noble, N.C., Leonard, B.S., 2019, Immunization Action Coalition. International Journal of Medicine, 76, 71-76

[3] McManus, L.M., Mitchell, R.N., 2014, Pathophysiology of Human Diseases; A Dynamic Encyclopedia of Disease Mechanisms. Elsevier Inc. Academic Press, 1-40

[4] Sukumaran, T. T., Joseph, S., Ramakrishnan, S., & Mathew, A. J., 2022, Anatomical variations of the hepatic artery in it’s extra hepatic journey: A cadaveric study with its clinical implications. Anatomy & Cell Biology, 55(3), 269-276. https://doi.org/10.5115/acb.22.043

[5] Wasley, A., Gallagher, K.M., Grytdal, S., 2008, Surveillance for acute viral hepatitis, United State, 2006. Centre for Disease Control and Prevention, 50(2), 1-24

[6] Shackel, N.A., Patel, K., McHutchison, J., 2013, Viral Hepatitis. Chapter - Genomic and Personalized Medicine (Second Edition). Academic Press, 1173-1190.

[7] Akhtar, S., Younus, M., Adil, S., Hassan, F., Jafri, S.H., Epidemiological study of chronic hepatitis B infection in male volunteer blood donors in Karachi, Pakistan. BMC Gastroenterol, 2005, 8, 5-26.

[8] Cox, A.L., El-Sayed, M.H., Kao, J.H., et al, 2020, Progress towards elimination goals for viral hepatitis. Nat Rev Gastroenterol Hepatol, 17, 533-542.

[9] Eke, A.C., Eke, U.A., Okafor, .CI., Ezebialu, I.U., Ogbuagu, C., 2011, Prevalence, Correlates and pattern of Hepatitis B surface antigen in a low resource setting. Virol J, 8, 12-21

[10] World Health Organization Regional Office for Africa, 2015, Hepatitis: Interim Guidance. World Health Organization, Geneva, Switzerland. Retrieved from htttps://www.who.int/publications-detail/hepatitis

[11] World Health Organization, 2013, Global policy report on Prevention and Control of Viral hepatitis in WHO Member States, WHO, Geneva.

[12] Chiang, C.J., Yang, Y.W., Yon, S.L., Lai, M.S., Chen, C.J., 2013, Thirty-Year outcomes of the national hepatitis B immunization program in Taiwan. JAMA, 4;310(9), 974-976.

[13] World Health Organization, 2014, Atlas of African Health Statistics, WHO Regional Office for Africa, Geneva.

[14] Otha, J.F., Ritchie, M.J., Dusheiko, G.M., Mouton, H.W., Kew, M.C., 1984, Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infection. Lancet, 2;1(8388):1210-2. doi: 10.1016/s0140-6736(84)91694-5. PMID: 6144925”.

[15] Federal Ministry of Health, 2019, Orientation Package for Health Care Providers.

[16] MCNellan, C.R., Dansereau, E., Wallance, M.C.G, et al, 2019, Antenatal care as a means to increase participation in the continuum of maternal and child healthcare: an analysis of the poorest region of four Mesoamerican countries. BMC Pregnancy Childbirth, 19, 66-72.

[17] Pham, T.T.H., Le, T.X.L., Nguyen D.T., et al, 2019, Knowledge, attitude and medical practice regarding hepatitis B prevention management among healthcare workers in Northern Vietnam. PloS one 14(10), e0223733.

[18] Hong, Z., Xiaying, Z., Yo Hua, Z., 2020, Hepatitis B vaccine development and implementation. Hum Vaccin Immunother, 1533-1544, Doi 10.1080/21645515.2020.1732166

[19] Sypsa, V., Hadjipaschali, E., Hatzakis, A., 2001, Prevalence, Risk Factors and Evaluation of a Screening Strategy for Chronic Hepatitis C and B Virus Infections in Healthy Company Employees, European Journal of Epidemiology, 17(8), 721-728.

[20] Eni, A.O., Soluade, M.G., Oshamika, O.O., Efekemo, O.P., Igwe, T.T., Onile-Ere, O.A., 2019, Knowledge and Awareness of Hepatiis B Virus Infection in Nigeria. Ann Glob Health, 11;85(1):56, doi: 10.5334/aogh.33. PMID: 30977623; PMCID: PMC6634363.

[21] Olorukooba, A.A., Earnest, E.C., Yahaya, S.S., Onoja-Alexander, M., Hamzat, K.L., Lawal, B. et al, 2018, Awareness and knowledge of HBV among students in tertiary institution in North western Nigeria. Int. Journal of Infectious Disease, 73(364): 1-9

[22] Rajamoorthy, Y., Taib, N.M.. Munusamy, S., et al. 2019, Knowledge and awareness of hepatitis B among households in Malaysia: a community-based cross-sectional survey. BMC Public Health, 19, 47-54. https://doi.org/10.1186/s12889-018-6375-8

[23] World Health Organization, 2018, Hepatitis B. Available from: http://www.who.int/news-room/fact-sheets/detail/hepatitis-b.

[24] Kheir, O.O., Freeland, C., Abdo, A.E., Muhamed Yousif, M.E., Altayeb, E.O., Mekonnem, H.D., et al. 2022, Assessment of hepatitis B knowledge and awareness among the Sudanese population in Khartoum State. PAMJ, 41(217): 1-8

[25] Ajuwon, B.I., Yujuico, I., Roper, K. et al, 2021, Hepatitis B virus infection in Nigeria: a systematic review and meta-analysis of data published between 2010 and 2019. BMC Infect Dis 21, 1120-35, https://doi.org/10.1186/s12879-021-06800-6

[26] Mac, P.A., Suleiman, A.C., Airiohuodion, P.E., 2019, High Prevalence of Hepatitis B Virus Infection among pregnant women attending Antenatal care in Central Nigeria. J Infect Dis Epidemiol, 5:068. doi.org/10.23937/2474-3658/1510068

[27] Awoleke, J., 2012, Hepatitis B surface antigenaemia among pregnant women in a tertiary health institution in Ekiti State, Nigeria. Tropical journal of obstetrics and gynaecology, 29, 34-39.

[28] Anaedobe, C., Nwadike Ugochukwu, V., Fowotade, A., et al, 2016, Hepatitis C Virus Infection among Pregnant Women in Ibadan, Nigeria: Prevalence, correlates and co-infection with HIV, International Journal of Tropical Disease and Health, 14,(1), 3-8.

[29] Kafeero, H.M., Ndagire, D., Ocama, P., Kudamba, A., Walusansa, A., Sendagire, H., 2021, Prevalence and predictors of hepatitis B virus (HBV) infection in east Africa: evidence from a systematic review and meta-analysis of epidemiological studies published from 2005 to 2020. Arch Public Health. 18;79(1):167. doi: 10.1186/s13690-021-00686-1. PMID: 34537079; PMCID: PMC8449462.

[30] Yohanes, T., Zerdo, Z., Chufamo, N., 2016, Seroprevalence and Predictors of Hepatitis B Virus Infection among Pregnant Women Attending Routine Antenatal Care in Arba Minch Hospital, South Ethiopia. Hepat Res Treat. 1-10, doi: 10.1155/2016/9290163.

[31] Weldebrhan, D., Berhe, H., Tesfay, Y., 2023, Risk Factors for Hepatitis B Virus Infection in North Ethiopia: A Case–Control Study. Hepat Med, 15, 79-91
https://doi.org/10.2147/HMER.S407069

[32] Zhao, X., Shi, X., Lv, M., Yuan, B., Wu, J., 2021, Prevalence and factors associated with hepatitis B virus infection among household members: A cross-sectional study in Beijing. Human Vaccines & Immunotherapeutics, 17(6), 1818-1824. https://doi.org/10.1080/21645515.2020.1847951

Abstract:

Gestational diabetes (GDM) can result in short-term and lasting health problems for the pregnant mother and the developing foetus. Instead of a sudden inflammatory response, GDM might trigger a chronic, low-level inflammation called "meta-inflammation." This persistent inflammation could play a role in the future development of diabetes, obesity, and cardiovascular issues for both the mother and child. Given this, the present study is an attempt to investigate the association between GDM and inflammation by evaluating the levels of interleukins. The study involved a total of 50 individuals, 25 pregnant women in gestational age 24 to 28 weeks as calculated by LMP and dating scan with gestational diabetes and 25 healthy pregnant women. Interleukin-10 and interleukin-6 levels were estimated by ELISA analysis. The plasma level of the anti-inflammatory marker IL-10 was significantly lower in the GDM group than in the healthy subjects group. Concomitantly the levels of pro-inflammatory cytokine IL-6 were found to be markedly increased in the GDM subjects in comparison to that of healthy subjects. Enhanced inflammatory response has been observed in GDM, suggesting that inflammatory markers could serve as predictive indicators for GDM. Delayed diagnosis could result in significant consequences for both the mother and the child, both in the short and long term. Hence, there is a pressing requirement for early markers of GDM to facilitate timely intervention and treatment. Exploring these inflammatory signals in greater detail presents an opportunity to enhance maternal health outcomes by creating focused and efficient therapeutic approaches.

References:

[1].   Chorell, E., Hall, U. A., Gustavsson, C., Berntorp, K., Puhkala, J., Luoto, R., Olsson, T., and Holmäng, A., 2017, Pregnancy to Postpartum Transition of Serum Metabolites in Women with Gestational Diabetes. Metabolism, 72, pp.27-36.

[2].   Kim, S. Y., Sappenfield, W., Sharma, A. J., Wilson, H. G., Bish, C. L., Salihu, H. M., and England, L. J., 2013, Racial/Ethnic Differences in the Prevalence of Gestational Diabetes Mellitus and Maternal Overweight and Obesity by Nativity Florida, 2004‐2007, Obesity, 21(1), pp.E33-E40.

[3].   Kim, C., Newton, K. M., and Knopp, R. H., 2002, Gestational Diabetes and the Incidence of Type 2 Diabetes: A Systematic Review, Diabetes Care, 25(10), pp.1862-1868.

[4].   Hotamisligil, G. S., 200, Inflammation and Metabolic Disorders, Nature, 444(7121), pp. 860-867.

[5].   Shoelson, S. E., Herrero, L. and Naaz, A., 2007, Obesity, Inflammation, and Insulin Resistance. Gastroenterology, 132(6), pp.2169-2180.

[6].   Donath, M. Y. and Shoelson, S. E., 2011, Type 2 Diabetes as an Inflammatory Disease. Nature Reviews Immunology, 11(2), pp.98-107.

[7].   Ehses, J. A., Perren, A., Eppler, E., Ribaux, P., Pospisilik, J. A., Maor-Cahn, R., Gueripel, X., Ellingsgaard, H., Schneider, M. K., Biollaz, G. and Fontana, A., 2007, Increased Number of Islet-Associated Macrophages in Type 2 Diabetes, Diabetes, 56(9), pp. 2356-2370.

[8].   Sobrevia, L., Salsoso, R., Fuenzalida, B., Barros, E., Toledo, L., Silva, L., Pizarro, C., Subiabre, M., Villalobos, R., Araos, J., and Toledo, F., 2016, Insulin is a Key Modulator of Fetoplacental Endothelium Metabolic Disturbances in Gestational Diabetes Mellitus, Frontiers in Physiology, 7, p.119.

[9].   Hajam, Y. A., Rai, S., Pandi-Perumal, S. R., Brown, G. M., Reiter, R. J. and Cardinali, D. P., 2022, Coadministration of Melatonin and Insulin Improves Diabetes-Induced Impairment of Rat Kidney Function. Neuroendocrinology, 112(8), pp.807-822.

[10].  Varadaiah, Y. G. C., Sivanesan, S., Nayak, S. B. and Thirumalarao, K. R., 2022, Purine Metabolites can Indicate Diabetes Progression, Archives of Physiology and Biochemistry, 128(1), pp.87-91.

[11].  Christian, L. M., and Porter, K., 2014, Longitudinal Changes in Serum Proinflammatory Markers Across Pregnancy and Postpartum: Effects of Maternal Body Mass Index, Cytokine, 70(2), pp.134-140.

[12].  Gomes, C. P., Torloni, M. R., Gueuvoghlanian‐Silva, B. Y., Alexandre, S. M., Mattar, R., and Daher, S., 2013, Cytokine Levels in Gestational Diabetes Mellitus: A Systematic Review of the Literature, American Journal of Reproductive Immunology, 69(6), pp.545-557.

[13].  Thorand, B., Kolb, H., Baumert, J., Koenig, W., Chambless, L., Meisinger, C., Illig, T., Martin, S. and Herder, C., 2005, Elevated Levels of Interleukin-18 Predict the Development of Type 2 Diabetes: Results from the Monica/Kora Augsburg Study, 1984–2002, Diabetes, 54(10), pp.2932-2938.

[14].  Brauner, H., Lüthje, P., Grünler, J., Ekberg, N. R., Dallner, G., Brismar, K., and Brauner, A., 2014, Markers of Innate Immune Activity in Patients with Type 1 and Type 2 Diabetes Mellitus and the Effect of the Anti-Oxidant Coenzyme Q10 On Inflammatory Activity, Clinical & Experimental Immunology, 177(2), pp.478-482.

[15].  Kang, J., Lee, C. N., Li, H. Y., Hsu, K. H., Wang, S. H. and Lin, S. Y., 2018, Association of Interleukin-10 Methylation Levels with Gestational Diabetes in a Taiwanese Population, Frontiers in genetics, 9, p. 222.

[16].  Elenkov, I. J., Wilder, R. L., Bakalov, V. K., Link, A. A., Dimitrov, M. A., Fisher, S., Crane, M., Kanik, K. S. and Chrousos, G. P., 2001, IL-12, TNF-α, and Hormonal Changes During Late Pregnancy and Early Postpartum: Implications for Autoimmune Disease Activity During these times, The Journal of Clinical Endocrinology & Metabolism, 86(10), pp.4933-4938.

[17].  Ni, J., Wang, Y., Zhu, J., Zheng, T., Yu, J. and Xiong, Y., 2022, Interleukin-10 Levels and Risk of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis, The Journal of Maternal-Fetal & Neonatal Medicine, 35(25), pp.7609-7616.

[18].  Van Exel, E., Gussekloo, J., de Craen, A. J., Frolich, M., Bootsma-Van Der Wiel, A. and Westendorp, R. G., 2002, Low Production Capacity of Interleukin-10 Associates with the Metabolic Syndrome and Type 2 Diabetes: The Leiden 85-Plus Study, Diabetes, 51(4), pp. 1088-1092.

[19].  Atègbo, J. M., Grissa, O., Yessoufou, A., Hichami, A., Dramane, K. L., Moutairou, K., Miled, A., Grissa, A., Jerbi, M., Tabka, Z. and Khan, N. A., 2006, Modulation of Adipokines and Cytokines in Gestational Diabetes And Macrosomia, The Journal of Clinical Endocrinology & Metabolism, 91(10), pp.4137-4143.

[20].  Al-Shukaili, A., Al-Ghafri, S., Al-Marhoobi, S., Al-Abri, S., Al-Lawati, J. and Al-Maskari, M., 2013, Analysis of Inflammatory Mediators in Type 2 Diabetes Patients, International Journal of Endocrinology, 2013.

[21].  Richardson, A. C. and Carpenter, M. W., 2007, Inflammatory Mediators in Gestational Diabetes Mellitus, Obstetrics and gynecology clinics of North America, 34(2), pp. 213-224.

[22].  Aktulay, A., Engin-Ustun, Y., Sahin Ozkan, M., Erkaya, S., Kara, M., Kaymak, O. and Danisman, N., 2015, Gestational Diabetes Mellitus Seems to be Associatied with Inflammation, Acta Clinica Croatica, 54(4.), pp.475-478.

[23].  Vrachnis, N., Belitsos, P., Sifakis, S., Dafopoulos, K., Siristatidis, C., Pappa, K. I. and Iliodromiti, Z., 2012, Role of Adipokines and Other Inflammatory Mediators in Gestational Diabetes Mellitus and Previous Gestational Diabetes Mellitus, International Journal of Endocrinology, 2012.

[24].  Wolf, M., Sauk, J., Shah, A., Smirnakis, K. V., Jimenez-Kimble, R., Ecker, J. L. and Thadhani, R., 2004, Inflammation and Glucose Intolerance. A Prospective Study of Gestational Diabetes Mellitus, Clinical Diabetology, 5(2), pp.85-94.

[25]. Xuan Nguyen, K., Bui Minh, T., Dinh, H. T., Viet Tran, T., Dinh Le, T., Phi Thi Nguyen, N., Tran, T. T. H., Hien Vu, T., Ho Thi Nguyen, L., Trung Nguyen, K., and Huy Thong, N., 2023, Low-Grade Inflammation in Gestational Diabetes Mellitus and its Correlation with Maternal Insulin Resistance and Fetal Growth Indices, International Journal of General Medicine, pp.1429-1436.

Abstract:

This study assessed knowledge, attitude, and practices of COVID-19 vaccination and other factors about vaccine uptake among residents of Abakaliki metropolis in Ebonyi State, Nigeria. A semi-structured questionnaire was used to collect data from four hundred (400) residents who formed the sample for the study. The majority of the respondents showed good knowledge of the non-legality of the COVID-19 vaccine. A few had adequate information and knowledge on the benefits of COVID-19 vaccine. Also, knowledge gaps exist among the respondents on vaccine eligibility and when protective immunity against COVID-19 will be achieved. The findings showed that news from TV/Radio, Government agencies, social media and discussions amongst friends, family and healthcare providers play important roles in influencing the respondents’ opinions regarding vaccination. It revealed that the general public’s intention to accept the COVID-19 vaccine is influenced by availability, storage and quality issues as well as the capacity of healthcare workers. It further suggests that attitude towards the COVID-19 vaccine has an important influence on the intention to take it. The findings showed that protection against COVID-19 infection; vaccines being available at no cost and eradicating COVID-19 infection were the main perceived benefits. Nigeria needs to employ different approaches to ensure that citizens exhibit positive attitudes towards the vaccine including using community meetings to pass information to the masses; training and using community members to increase access to correct information; conducting community engagement activities to improve acceptance; and using social media to provide correct information on personal risk and susceptibility to COVID-19 disease

References:

[1].   World Health Organization (WHO), (2020). COVID-19 Vaccine Tracker and Landscape. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

[2].   World Health Organisation (2022). Weekly Epidemiological Update on COVID-19. Available via: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---14-september-2022

[3].   National Centre for Disease Control (2022). COVID-19 Nigeria. Available via: https://covid19.ncdc.gov.ng/covid19update

[4].   Nicola, M., Alsafi, Z., Sohrabi, C. and Kerwan A. (2021). The Socio-Economic Implications of the Coronavirus Pandemic (COVID-19): A Review. Int J Surg. (2020) 78:185–93.

[5].   Geoghegan, S., O'Callaghan, K. P. and Offit, P. A. (2020). Vaccine Safety: Myths and Misinformation. Frontier Microbiology, Vol. 11, pp. 372-389.

[6].   Afia, U. U; Obot, V. O; Johnson, N. I. (2022). Knowledge, Attitude and Acceptability of COVID-19 Vaccination among Lecturers in Universities in Akwa Ibom State, International Journal of Ebola, AIDS, HIV and Infectious Diseases and Immunity, Vol. 7, No. 1, pp. 38-50

[7].   Aliyu, Murtala and Gora, Abbas Adamu Lamido, “Acceptance and Attitude toward Vaccination against COVID-19: A Cross-Sectional Study of Academic Librarians in Nigeria.” (2023). Library Philosophy and Practice (e-journal). 7488. https://digitalcommons.unl.edu/libphilprac/7488

[8].   Afolabi, M. O., Wariri, O., Saidu, Y., Otu, A., Omoleke, S. A., Ebenso, B., Adebiyi, A., Ooko, M., Ahinkorah, B. O. & Ameyaw, E. K. et al., (2021). Tracking the Uptake and Trajectory of COVID-19 Vaccination Coverage in 15 West African Countries: An Interim Analysis. BMJ Global Health, 6, e007518.

[9].   National Primary Health Care Development Agency (NPHCDA) (2021). COVID-19 Vaccination Update. Available via: https://nphcda.gov.ng/2021/10/20/covid-19/

[10].  Dror A A, Eisenbach N, Taiber S, et al. (2020). Vaccine Hesitancy: The Next Challenge in the Fight Against COVID-19. Eur J Epidemiol. 35(8):775–779. doi: 10.1007/s10654-020-00671-y

[11].  Liu Q., Qin C., Liu M., Liu J., (2021). Effectiveness and Safety of SARS-CoV-2 Vaccine in Real-World Studies: A Systematic Review and Meta-Analysis. Infect Dis Poverty. 10(1):1–15. doi: 10.1186/s40249-021-00915-3. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

[12].  Karlsson L. C., Soveri A., Lewandowsky S., et al., (2021). Fearing the Disease or the Vaccine: The Case of COVID-19. Pers Indiv Differ. 172. doi: 10.1016/j.paid.2020.110590. [PMC free article] [PubMed] [CrossRef] [Google Scholar].

[13].  Andrade C, Menon V, Ameen S, et al., (2020). Designing and Conducting Knowledge, Attitude, and Practice Surveys in Psychiatry: Practical Guidance. Indian J Psychol Med. 42(5):478–481. doi: 10.1177/0253717620946111.

[14].  Voysey M, Clemens S A C, Madhi S A, Weckx LY, Folegatti P M, Aley P K, et al., (2021). Safety and Efficacy of the ChAdOx1 nCoV-19 Vaccine (AZD1222) Against SARS-CoV-2: An Interim Analysis of Four Randomised Controlled Trials in Brazil, South Africa, and the UK. Lancet. 397:99–111. doi: 10.1016/S0140-6736(20)32661-1.

[15].  MacDonald N E. (2015). Vaccine Hesitancy: Definition, Scope and Determinants. Vaccine. 33:4161–4. doi: 10.1016/j.vaccine.2015.04.036.

[16].  Yisak H, Ambaw B, Belay E, Desalegn T, Getie A, Asrat M, Guangul A, Seid T, Zewde E A, Assefa M and Ewunetei A (2022) Knowledge, Attitude, Acceptance, and Practice of COVID-19 Vaccination and Associated Factors Complemented with Constructs of Health Belief Model Among The General Public in South Gondar, Ethiopia: A Community-Based Study. Front. Public Health 10:914121. doi: 10.3389/fpubh.2022.914121(Author).

[17].  Chinnasamy N, Adhimoolam M. (2023). Knowledge, Attitude, Practice and Acceptability Towards Covid-19 Infection and Vaccination – A Community-Based Study. Natl J Physiol Pharm Pharmacol 13(10):2172-2177. Doi: 10.5455/njppp.2023.13.04174202308042023.

[18].  Danso D. (2021). Assessing Efficient Cold Chain Management Practices in the Health Sector and its Impact on Service Delivery in Ghana: A Study of Komfo Anokye Teaching Hospital, KUMASI. Master’s Thesis, Kwame Nkrumah University of Science and Technology

[19].  Sialubanje C, Mukumbuta N, Ng'andu M, et al., (2022). Perspectives on the COVID-19 Vaccine Uptake: A Qualitative Study of Community Members and Health Workers In Zambia. BMJ Open: 12:e058028. doi:10.1136/bmjopen-2021-058028.

[20].  Burke et al., (2021). Enablers and Barriers to COVID-19 Vaccine Uptake: An international Study of Perceptions and Intentions. Vaccine, 39, pp. 5116-5128 http://dx.doi.org/10.1016/j.vaccine.2021.07.056

[21].  Ackah et al., (2022) COVID-19 Vaccine Hesitancy in Africa: A Scoping Review. Global Health Research and Policy, 7, pp. 1-20 http://dx.doi.org/10.1186/s41256-021-00234-y

[22].  Ferrer R, Klein W M, William M K. (2015). Risk Perceptions and Health Behavior. Curr Opin Psychol 5:85–9. doi: 10.1016/j.copsyc.2015.03.012.

[23].  Elhadi, M., Alsoufi, A., Alhadi, A. et al., (2021). Knowledge, Attitude, and Acceptance of Healthcare Workers and the Public Regarding the COVID-19 Vaccine: A Cross-Sectional Study. BMC Public Health 21, 955. https://doi.org/10.1186/s12889-021-10987-3

Abstract:

The purpose of this study was to explore the perception regarding cold chain service delivery about the service delivery of COVID-19 vaccine among healthcare workers in Abakaliki, Ebonyi State, Nigeria. An exploratory survey approach was used and entailed the collection of quantitative data from forty-five (45) healthcare workers selected from forty-five health centres in fifteen (15) study districts. The findings reveal that a greater number of the respondents have a good knowledge of the usefulness of cold chain practices in managing the logistics system and cold chain supply from the beginning to the end of the process. The respondents perceived efficient cold chain delivery practices to have a significant impact on COVID-19 service delivery hence if strengthened will in turn lead to the availability of high-quality vaccines. A greater number of the respondents perceived inadequate storage facilities or cold chain capacity; transportation delays; absence of other sources of power and lack of dependable transportation as the greatest challenges that affect the cold chain provision of COVID-19 vaccines. Nigeria should sustain its vaccination efforts as an effective way to eliminate the burden of COVID-19 infection by strengthening its supply chain system using evidence-based interventions aimed at revamping and upgrading the cold stores’ infrastructures; ensuring regular power supply/providing backup power supply to maintain the quality of vaccines during storage; strengthening inventory management system at the state and local government areas and training/retraining of key officers on supply chain management of COVID-19 vaccine.

References:

[1].   Liu, Y., Gayle, A. A., Wilder-Smith, A., & Rocklöv, J., 2020, The Reproductive Number of Covid-19 is Higher Compared to Sars Coronavirus. Journal of Travel Medicine, 27(2), taaa021. https://doi.org/10.1093/jtm/taaa021.

[2].   Fahrni, M. L., Ismail, I. A N., Refi, D. M. et al., 2022, Management of COVID-19 Vaccines Cold Chain Logistics: a Scoping Review. J of Pharm Policy and Pract., 15, 16. https://doi.org/10.1186/s40545-022-00411-5

[3].   Ivanov, D., 2020, Predicting the Impacts of Epidemic Outbreaks On Global Supply Chains: A Simulation-Based Analysis on the Coronavirus Outbreak (COVID-19/SARS-CoV-2) case. Transportation Research Part E: Logistics and Transportation Review, 136, 101922.

[4].   Peter, L. L., Schroeder, L., Oliveira, F. N., & Leiras, A, 2023, Logistics of Covid-19 Vaccines: Main Challenges in Theory and Practice. Production, 33, e20220036. https://doi.org/10.1590/0103-6513.20220036.

[5].   Flaxman S, Mishra S, Gandy A, et al., 2020, Estimating the Effects of Non-Pharmaceutical Interventions on COVID-19 in Europe. Nature; 7820:257–61.

[6].   Vijayaraghavan P, Sriramkumar S. R., 2021, Non-Pharmaceutical Interventions are Measures to Control Coronavirus Disease-2019 COVID-19) Transmission in India. Coronaviruses, 3:278–83.

[7].   Lai S, Ruktanonchai N. W, Zhou L. et al., 2020, Effect of Non-Pharmaceutical Interventions to Contain COVID-19 in China. Nature;7825:410–3.

[8].   WHO (2020). Coronavirus Disease (COVID-19): Herd Immunity, Lockdowns and COVID-19. World Health Organization (WHO). Published 2020. Accessed May 17, 2023. https://www.who.int/news-room/questionsand-answers/item/herd-immunity-lockdowns-and-covid-19

[9].   Adebisi Y. A, Alaran A. J, Bolarinwa O. A, et al., 2021. When it is Available, will we take it? Social Media Users’ Perception of Hypothetical COVID-19 Vaccine in Nigeria. Pan Afr Med J, 38:230.

[10].  Jiang, P., Klemeš, J. J., Van Fan, Y., Fu, X., Tan, R. R., You, S., & Foley, A. M. (2021). Energy, Environmental, Economic And Social Equity (4E) Pressures of COVID-19 Vaccination Mismanagement: A Global Perspective, Energy, 235, 121315.

[11].  Andoh, E. A., Yu, H., 2023). A two-Stage Decision-Support Approach for Improving Sustainable Last-Mile Cold Chain Logistics Operations of COVID-19 Vaccines. Ann Oper Res., 328, 75–105. https://doi.org/10.1007/s10479-022-04906-x

[12].  Ogunniyi, Tolulope Joseph B.MLS^a; Rufai, Basirat Oluwadamilola B.Pharm^b; Uketeh, Sunday Nguher Pharm. D^c; Turzin, Justice Kwadwo BSc^h; Oyinloye, Emmanuel Abiodun BSc^d; Effiong, Fortune Benjamin B.MLS^e,f,g, (2023). Two years of COVID-19 Vaccination in Nigeria: A Review of the Current Situation of the Pandemic: A Literature Review. Annals of Medicine & Surgery 85(11):p 5528-5532, DOI: 10.1097/MS9.0000000000001310.

[13].  Gevaers, R., Van de Voorde, E., & Vanelslander, T., 2011, Characteristics and Typology of Last-Mile Logistics from an Innovation Perspective in an Urban context. In C. Macharis & S. Melo (Eds.), City Distribution and Urban Freight Transport. Cheltenham, Reino Unido: Edward Elgar Publishing. http://dx.doi.org/10.4337/9780857932754.00009.

[14].  United Nations Organisation (2016). Transforming our World: The 2030 Agenda For Sustainable Development.

[15].  Chukwu O. A, Chukwu U, Lemoha C., 2018). Poor Performance of Medicines Logistics and Supply Chain Systems in a Developing Country Context: Lessons from Nigeria. J Pharm Heal Serv Res.;9:289–91.

[16].  Aigbavboa S, Mbohwa C. (2020). The Headache of Medicines’ Supply in Nigeria: An Exploratory Study on the Most Critical Challenges of Pharmaceutical Outbound Value Chains. In: Procedia Manufacturing. Elsevier B. V. 336–43. 10.1016/j.promfg.2020.02.170.

[17].  Olutuase V. O, Iwu-Jaja C. J, Akuoko C. P, Adewuyi E. O, Khanal V., 2022, Medicines and Vaccines Supply Chains Challenges in Nigeria: A Scoping Review. BMC Public Health. Jan 5; 22(1):11. Doi: 10.1186/s12889-021-12361-9. PMID: 34986820; PMCID: PMC8727467.

[18].  Gupta, S. S., Nair, G. B., Arora, N. K. and Ganguly, N. K., 2013, “Vaccine Development and Deployment: Opportunities and Challenges in India”, Vaccine, Elsevier, Vol. 31, No. SUPPL2, pp. B43-B53.

[19].  Subhodeep Mukherjee et al., 2023, Journal of Humanitarian Logistics and Supply Chain Management. 13/2 199–215 Emerald Publishing Limited [ISSN 2042-6747] [DOI 10.1108/JHLSCM-08-2021-0079]

[20].  https://www.who.int/teams/immunization-vaccines-and-biologicals/essential-programme-on-immunization/supply-chain

[21].  https://www.unicef.org/supply/what-cold-chain (UNICEF Supply chain division).

[22].  Danso D., 2021, Assessing Efficient Cold Chain Management Practices in the Health Sector and its Impact On Service Delivery in Ghana: A Study of Komfo Anokye Teaching Hospital, KUMASI. Master’s Thesis (unpublished), Kwame Nkrumah University of Science and Technology, Ghana.

Abstract:

Tuberculosis (TB) has afflicted humans for millennia and continues to pose a significant threat to public health worldwide. The World Health Organization classified TB as one of the top 10 causes of death globally, with approximately 10 million new cases and 1.4 million TB associated deaths in 2019 alone. Tuberculosis has high prevalence rates in certain regions, including Nigeria. Traditional diagnostic methods for TB and drug resistance diagnosis have limitations in accuracy and speed, highlighting the need for continuous studies on advanced molecular techniques. The study assessed the prevalence of tuberculosis and drug resistance among patients attending the National Tuberculosis and Leprosy Training Centre (NTBLTC), Saye Zaria using molecular techniques, with the aim of contributing to the improvement of diagnosis, treatment, and control strategies for tuberculosis. The cross-sectional study involved 342 suspected TB patients. Samples collected were analysed by microscopy, GeneXpert MTB/RIF and Line probe Assays. The results of this study showed an overall prevalence rate of 39.5% (p<0.05) of Mycobacterium Tuberculosis determined from GeneXPert MTB/RIF positive confirmed cases. further assay using Line Probe Assay (LPA) revealed an MDR-TB prevalence rate of 18(5.3%). Poly-resistance was also detected in 2 (0.58%). However, no Pre-Extensively Drug Resistant Tuberculosis (Pre-XDR-TB) and Extensively Drug Resistant-Tuberculosis (XDR-TB) were found. The overall results showed a slight but comparable rise in the prevalence of MTB against reviewed studies while the MDR-TB prevalence was lower. The study underscores the need for early diagnosis and treatment of TB to stall the occurrence of MDR-TB and other forms of severe TB infections.

References:

[1].   The World Health Organization (Global Tuberculosis Control: WHO Report 2010), Date of Access: 1/1/2011, https://www.who.int/publications/i/item/9789241564069.

[2].   Aliyu G., El-Kamary, S. S., Abimiku, A., Ezati, N., Mosunmola, I., Hungerford, L., Brown, C., Tracy, K. J., Obasanya, J., Blattner, W., 2013, Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria. Tuberculosis Research Treatment, Doi: 10.1155/2013/650561.

[3].   Bassey, E. B., Momoh, M. A., Imadiyi, S. O., Udofia, E. B., Miri, F. S., Anukam, K. C., Epoke, J., Benka-Coker, M. O., Aluyi, H. S., 2005, The Trend of Pulmonary Tuberculosis in Patients Seen at DOTS Clinics in the Federal Capital Territory, Abuja, Nigeria. Public Health, 119(5):405-8. Doi: 10.1016/j.puhe.2004.05.012.

[4].   Iliyasu, Z, Babashani, M., 2009, Prevalence and Predictors of Tuberculosis Coinfection Among HIV-Seropositive Patients Attending the Aminu Kano Teaching Hospital, Northern Nigeria, J Epidemiol. 19(2):81-7. Doi: 10.2188/jea.je20080026.

[5].   World Health Organisation (Global Tuberculosis Control: A Short Update to the 2009 report), Date of Access:1/1/2009, https://www.who.int/publications/i/item/9789241598866.

[6].   World Health Organisation (Global Tuberculosis Report 2020), Date of Access: 15/10/2020, https://www.who.int/publications/i/item/9789240013131.

[7].   World Health Organisation, (Global Tuberculosis Report 2023), Date of Access: 7/11/2023, https://reliefweb.int/report/world/global-tuberculosis-report-2023

[8].   Mac-Fiberesima, G., Ayodele, M. B. O., and Aaron, U. U., Baseline Evaluation of the Shorter Regimen for Multidrug Resistant Tuberculosis in South-South, Nigeria. Sokoto Journal of Medical Laboratory Science, 4(3):54-61, https://www.researchgate.net/profile/Martins-Ayodele-2/publication/336775153.

[9].   Natasha N., and Manormoney P., 2017, Bacterial pili, with Emphasis on Mycobacterium Tuberculosis Curli Pili: Potential Biomarkers for Point – of care Tests And Therapeutics. Biomarkers; 22(2):93 – 105. DOI: 10.1080/1354750X.2016.1252960

[10].  World Health Organization, (Global Tuberculosis Report 2016). Date of Access: 7/11/2023, https://www.who.int/teams/global-tuberculosis-programme/tb-reports.

[11].  World Health Organization (Implementing Tuberculosis Diagnostics: A Policy Framework), Date of Access: 24/04/2015, https://www.who.int/publications/i/item/9789241508612.

[12].  Boehme, C. C., Nabeta, P, Hillemann, D., Nicol, M.P., Shenai, S., Krapp, F., Allen, J., Tahirli R., Blakemore, R., Rustomjee, R., Milovic, A., Jones M., O'Brien S. M., Persing, D. H., Ruesch-Gerdes, S., Gotuzzo, E., Rodrigues, C., Alland, D., Perkins, M. D.,2010, Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. N Engl J Med., 363(11):1005-15. Doi: 10.1056/NEJMoa0907847.

[13].  Oladimeji, O., Atiba, B. P., Anyiam, F. E., Odugbemi, B. A., Afolaranmi, T., Zoakah, A. I., Horsburgh, C. R., 2023, Gender and Drug-Resistant Tuberculosis in Nigeria. Trop. Med. Infect. Dis., 8, 104. https://doi.org/10.3390/tropicalmed8020104.

[14].  Bai, Y., Wang, Y., Shao, C., Hao, Y., and Jin, Y., 2016, GenoType MTBDRplus assay for Rapid Detection of Multidrug Resistance in Mycobacterium Tuberculosis: A Meta-Analysis. PLoS ONE 11:e015032. Doi: 10.1371/journal.pone.0150321.

[15].  Javed, H., Bakuła, Z., Plen, M., ´Hashmi, H. J., Tahir, Z., Jamil, N., and Jagielski, T., 2018, Evaluation of Genotype MTBDRplus and MTBDRsl Assays for Rapid Detection of Drug Resistance in Extensively Drug-Resistant Mycobacterium Tuberculosis Isolates in Pakistan. Front. Microbiol. 9:2265. Doi: 10.3389/fmicb.2018.02265.

[16].  Hain Lifescience (GenoType MTBDRplus VER 2.0.) 2019, Identification of the M. Tuberculosis Complex and its Resistance to Rifampicin and/or Isoniazid from Pulmonary Clinical Specimens or Cultivated Samples. https://www.hain-lifescience.de/en/products/microbiology/mycobacteria/tuberculosis/genotype mtbdrplus.html.

[17].  Pius, O., John, A., Sunday, O., Mumini, A., 2020, Occurrence of Rifampicin Resistant and HIV Co-Infection Tuberculosis in Ikere-Ekiti, Nigeria. Mal J Med Health Sci 16(1): 168-172.

[18].  Onaiwu T. O., Judith O., Philomena E., Adeyemi T. K., Taofeek S. A., Isaac O. K., 2023, Gene Mutation Patterns of Mycobacterium Tuberculosis Complex and Associated Factors among Suspected Multidrug-Resistant Tuberculosis Patients in Osun State, South-West, Nigeria, Scientific African 22 (2023) e01968 https://doi.org/10.1016/j.sciaf.2023.e01968.

[19].  Lawson, L., Habib, A. G., Okobi, M. I., Idiong, D., Olajide, I., Emenyonu, N., Onuoha, N., Cuevas, L. E. & Ogiri, S. O., 2010, Pilot Study on Multidrug Resistant Tuberculosis in Nigeria, Annals of African Medicine, Vol. 9, No. 3, pp. 184-187.

[20].  Lawson, L., Yassin, M. A., Abdurrahman, S. T., Parry, C. M., Dacombe, R., Sogaolu, O. M., Ebisike, J. N., Uzoewulu, G. N., Lawson, L. O., Emenyonu, N., Ouoha, J. O., David, J. S., Davies, P. D. O. and Cuevas, L. E. 2011, Resistance to First-Line Tuberculosis Drugs in Three Cities of Nigeria. Tropical Medicine & International Health, 16: 974-980. https://doi.org/10.1111/j.1365-3156.2011.02792.x.

[21].  Daniel O., and Osman E., 2011, Prevalence and Risk Factors Associated with Drug Resistant TB in South West, Nigeria, Asian Pacific Journal of Tropical Medicine, Vol. 4, no. 2, pp. 148–151. Doi:10.1016/S1995-7645(11)60057-6.

[22].  Aminu, A. I. and Tukur, A. D., 2016, Detection of Multidrug Resistant Tuberculosis (mdr-tb) among Rifampicin-Resistant tb Patients Using Line Probe Assay (lpa) in Kano, Nigeria. Bayero Journal of Pure and Applied Sciences, 9(2): 1 – 8. http://dx.doi.org/10.4314/bajopas.v9i2.1.

[23].  Akwaowo, C. D, Ekpin, V ., Umoh, V., Jiman, O., Bassey, A., Antia, E., Usoroh, E., 2021, Prevalence and Outcomes of Multi Drug Resistant Tuberculosis in Akwa Ibom STATE NIGERIA: A Retrospective Study, World Journal of Applied Science and Technology, 13(1), 10 – 18. https://www.ajol.info/index.php/wojast/issue/view/20826.

[24].  Lin, Y. H., Tai , C. H., Li, C. R., Lin, C. F., Shi, Z. Y., 2012, Resistance Profiles and rpoB Gene Mutations of Mycobacterium Tuberculosis Isolates in Taiwan. J Microbiol Immunol Infect. 46(4):266-70. Doi: 10.1016/j.jmii.2012.06.008.

[25].  Rufai, S. B., Kumar, P., Singh, A., Prajapati, S., Balooni, V., Singh, S., 2014, Comparison of Xpert MTB/RIF with Line Probe Assay For Detection Of Rifampin-Monoresistant Mycobacterium Tuberculosis. J Clin Microbiol. 52(6):1846-52. Doi: 10.1128/JCM.03005-13.

Abstract:

Medication usage during pregnancy is increasing twofold, and it should be considered a public health issue due to increasing complications associated with medication. Data on prescribed and self-prescribed medication among Sudani females is limited. Hence, this study aims to assess the prevalence and associated risk factors of drug usage among Sudanese females, including prescribed medication and self-prescribed medication, who are registered in tertiary care facilities. A cross-sectional descriptive study was planned in the hospital setting at Omdurman Maternity Center, Sudan. Data were collected between January 2023 and February 2023 through semi-structured interviews. The sample comprised 878 pregnant females and was divided into two groups: 453 females on medication and 425 females not on medication. The data were analyzed using univariate and multivariate logistic regression, and statistical significance was set at 0.05. The result of this study shows that 51.1% of females were on medication, of which 14.1% were on self-medication. The maximum drugs taken were antibiotics, followed by diabetic and hypertensive medication. Data showed a statistically significant relationship between medicine usage and chronic medical conditions (p<0.001). However, no significant association was reported between medicine usage, body mass index, gravidity, maternal age, and education. The prevalence of medicine usage among Sudani women is high. These findings underscore the importance of enhancing the initiatives undertaken by healthcare professionals, particularly in the prenatal setting, to ensure the appropriate management of medication usage during pregnancy, thereby reducing the risk of potential complications for both the mother and the fetus.

References:

[1].   KHOa, J. V, CHUAab S. S., DALLUMAL, R. M., OMAR,  S. Z., 2017, Medications used by Pregnant Women: any Safety Concerns? Malay. 318:63.6.

[2].   Lupattelli A, Spigset O, Twigg M. J., et al., 2014, Medication Use in Pregnancy: A Cross-Sectional, Multinational Web-Based Study. BMJ Open. Feb 17 4(2):e004365. doi:10.1136/bmjopen-2013-004365

[3].   Mitchell, A. A., Gilboa, S. M., Werler, M. M., Kelley, K. E., Louik, C., Hernández-Díaz, S., 1976-2008, Medication Use During Pregnancy, with Particular Focus on Prescription Drugs:. Am J Obstet Gynecol. Jul 2011; 205(1):51.e1-8. Doi:10.1016/j.ajog.2011.02.029

[4].   Mohammed, M. A., Ahmed, J. H., Bushra, A. W., Aljadhey, H. S., 2013, Medications use among Pregnant Women in Ethiopia: A Cross Sectional Study. Journal of Applied Pharmaceutical Science.; 3(4):116-123.

[5].   Obadeji, S. T., Obadeji, A., Bamidele, J. O., Ajayi, F. T., 2020, Medication use Among Pregnant Women at A Secondary Health Institution: Utilisation Patterns and Predictors of Quantity. Afr Health Sci. Sep 20(3):1206-1216. Doi:10.4314/ahs.v20i3.24

[6].   Haque, M. U., Khatun, M. S., Amin, N. T., et al. 2016, Prevalence and Nature of Selfmedication of Drugs Among Pregnant Women in Rajshahi City, Bangladesh. European Journal of Preventive Medicine. 4(6):125-131.

[7].   Mulder, B., Bijlsma, M. J., Schuiling-Veninga, C. C., et al. 2018, Risks Versus Benefits of Medication use During Pregnancy: What Do Women Perceive? Patient Prefer Adherence. 12:1-8. Doi:10.2147/ppa.S146091.

[8].   Pereira, G., Surita, F. G., Ferracini, A. C., Madeira, C. S, Oliveira, L. S, Mazzola, P. G., 2021, Self-Medication Among Pregnant Women: Prevalence and Associated Factors. Front Pharmacol. 12:659503. Doi:10.3389/fphar.2021.659503.

[9].   Sachdeva, P., Patel, B. G., Patel, B. K. 2009, Drug use in Pregnancy; A Point to Ponder! Indian J Pharm Sci. Jan 71(1):1-7. Doi:10.4103/0250-474x.51941

[10].  Devkota, R, Khan, G. M, Alam, K, Sapkota, B, Devkota, D. 2017, Impacts of Counseling on Knowledge, Attitude and Practice of Medication Use During Pregnancy. BMC Pregnancy Childbirth. Apr 27 17(1):131. Doi:10.1186/s12884-017-1316-6.

[11].  Trønnes, J. N, Lupattelli, A., Nordeng, H., 2017, Safety Profile of Medication Used During Pregnancy: Results of a Multinational European Study. Pharmacoepidemiol Drug Saf. Jul 26(7):802-811. Doi:10.1002/pds.4213

[12].  Cleary, B. J, Butt, H., Strawbridge, J. D, Gallagher, P. J., Fahey, T., Murphy, D. J. 2010, Medication Use in Early Pregnancy-Prevalence and Determinants of Use in A Prospective Cohort of Women. Pharmacoepidemiol Drug Saf. Apr 19(4):408-17. Doi:10.1002/pds.1906.

[13].  Suthar, J, Patel, R., 2020, Morbidity Pattern and Drug Prescribing Study in Pregnant Women of Rural Part of Charotar Region. Indian Journal of Pharmacy Practice. 13(4)

[14].  Alsammani, M. A., 2021, Incidence and Causes of Stillbirth in Omdurman Maternity Hospital, Sudan: A Prospective Cross-Sectional Study. Cureus. Jun 13(6):e15453. Doi:10.7759/cureus.15453.

[15].  Bader, E, Alhaj, A. M, Hussan, A. A, Adam, I. 2010, Malaria and Stillbirth in Omdurman Maternity Hospital, Sudan. International Journal of Gynecology & Obstetrics. 109(2):144-146. Doi:https://doi.org/10.1016/j.ijgo.2009.11.022.

[16].  Sullivan, K. M, Dean, A, Soe, M. M. 2009, OpenEpi: A Web-Based Epidemiologic and Statistical Calculator For Public Health. Public Health Rep. May-Jun 124(3):471-4. Doi:10.1177/003335490912400320.

[17].  Beyene, K. G, Beza, S. W., 2018, Self-Medication Practice and Associated Factors Among Pregnant Women in Addis Ababa, Ethiopia. Trop Med Health. 46:10. Doi:10.1186/s41182-018-0091-z.

[18].  Hanafy, S. A, Sallam, S. A, Kharboush, I. F., Wahdan, I. H., 2016, Drug Utilization Pattern During Pregnancy in Alexandria, Egypt. Eur J Pharm Med Res. 3(2):19-29.

[19].  Dathe, K, Schaefer, C. 2019, The Use of Medication in Pregnancy. Dtsch Arztebl Int. 116(46):783-790. Doi:10.3238/arztebl.2019.0783

[20].  Araújo, D. D., Leal, M. M., Santos, E. J. V., Leal, L. B., 2013, Consumption of Medicines in High-Risk Pregnancy: Evaluation of Determinants Related to the use of Prescription Drugs and Self-Medication. Brazilian Journal of Pharmaceutical Sciences. 49:491-499.

[21].  Iranpour, A, Kazemian, E, Karamoozian, A, Nakhaee, N, Sharifi, H, Fadakar, M. M., 2023, Prevalence of Substance Use During Pregnancy and the Related Factors: A Study from Southeast Iran. Journal of. 30(5):261-266.

[22].  Tabatabaei, S. M., Behmanesh-Pour, F., Salimi-Khorashad, A., Zaboli, M., Sargazi-Moakhar, Z., Shaare-Mollashahi, S., 2018, Substance Abuse and its Associated Factors Among Pregnant Women: A Cross-Sectional Study in the Southeast of Iran. Addiction & health. 10(3):162.

[23].  Admasie, C, Wasie, B, Abeje, G., 2014, Determinants of Prescribed Drug Use Among Pregnant Women in Bahir Dar City Administration, Northwest Ethiopia: A Cross Sectional Study. BMC Pregnancy Childbirth. 14:325. Doi:10.1186/1471-2393-14-325.

[24].  Tamiru, D., Misgana, T., Tariku, M, et al. 2022, Prevalence and Associated Factors of Common Mental Disorders Among Pregnant Mothers in Rural Eastern Ethiopia. Frontiers in Psychiatry. 13:843984.

[25].  Ayele, Y., Mekuria, A. N., Tola, A., Mishore, K. M., Geleto, F. B., 2020, Prescription Drugs Use During Pregnancy In Ethiopia: A Systematic Review and Meta-Analysis. SAGE Open Med. 8:2050312120935471. Doi:10.1177/2050312120935471.

[26].  Atmadani, R. N., Nkoka, O., Yunita, S. L., Chen, Y. H., 2020, Self-Medication and Knowledge Among Pregnant Women Attending Primary Healthcare Services in Malang, Indonesia: A Cross-Sectional Study. BMC Pregnancy Childbirth. Jan 16 20(1):42. Doi:10.1186/s12884-020-2736-2.

[27].  Baraka, M., Steurbaut, S., Coomans, D, Dupont, A. G., 2014, Determinants of Medication Use in A Multi-Ethnic Population of Pregnant Women: A Cross-Sectional Study. Eur J Contracept Reprod Health Care. 19(2):108-20. doi:10.3109/13625187.2013.879568

Abstract:

This significant study aimed to determine Ghanaian nurses' knowledge, perception, and preparedness for a pandemic or another wave of COVID-19. This comprehensive, cross-sectional study was conducted between May and July 2023. The questionnaire, a crucial tool, was distributed through Facebook, WhatsApp, and other social media links. A total of 1347 responses from the nurses, a substantial number, were collected from all 16 regions of Ghana. The inclusion criteria, a key aspect, are based on the in-service nurses directly linked with hospitals and medical facilities who had direct contact with patients. About twice the number of female nurses (906, 67.3%) responded to the survey compared to 441, 32.7% (males). As the study reveals, Ghanaian nurses were knowledgeable, had a good perception, and were prepared for a pandemic or another wave of Covid-19. There was a strong correlation, a significant finding, between the nurse's years of practice and the risk of perception. Also, female nurses (67.3%) know more about the virus spread and treatment than their male counterparts (32.7%). Unfortunately, the level of preparedness for a pandemic or another wave of COVID-19 was low.

References:

[1] Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., & Lu, R. (220). A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine, 382(8), 727-733.

[2] WHO (2020). WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020. Geneva, Switzerland, 3-5.

[3] Sohrabi, C., Alsafi, Z., O'neill, N., Khan, M., Kerwan, A., Al-Jabir, A., Iosifidis, C., & Agha, R. (2020). World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International journal of surgery, 76, 71-76.

[4] WHO (2007). Infection prevention and control of epidemic-and pandemic-prone acute respiratory diseases in health care: WHO interim guidelines.

[5] Chang, D., Xu, H., Rebaza, A., Sharma, L., & Cruz, C. S. D. (2020). Protecting health-care workers from subclinical coronavirus infection. The Lancet Respiratory Medicine, 8(3), e13.

[6] Nagesh, S., & Chakraborty, S. (2020). Saving the frontline health workforce amidst the COVID-19 crisis: Challenges and recommendations. Journal of Global Health, 10(1).

[7] Kyei-Arthur, F., Agyekum, M. W., Afrifa-Anane, G. F., Larbi, R. T., & Kisaakye, P. (2023). Perceptions about COVID-19 preventive measures among Ghanaian women. Plos one, 18(4), e0284362.

[8] Ussif, A. M., Egbenya, D. L., Kusi, J. D., Nyarko, E., Quartey, P., Boateng, I., Ulanja, M. B., Affram, K. O., Tsegah, K. M., & Djankpa, F. T. (2023). We assess knowledge and awareness of COVID-19 among traders and sanitary workers in the Cape Coast Metropolis of Ghana—Journal of Global Health Reports, 7, e2023029. Saba, C. K. S. (2020). COVID-19: implications for food, water, hygiene, sanitation, and environmental safety in Africa: a case study in Ghana.

[9] Barnett, D. J., Thompson, C. B., Errett, N. A., Semon, N. L., Anderson, M. K., Ferrell, J. L., Freiheit, J. M., Hudson, R., Koch, M. M., & McKee, M. (2012). Determinants of emergency response willingness in the local public health workforce by jurisdictional and scenario patterns: a cross-sectional survey. BMC Public Health, 12, 1-11.

[10] Ives, J., Greenfield, S., Parry, J. M., Draper, H., Gratus, C., Petts, J. I., Sorell, T., & Wilson, S. (2009). Healthcare workers' attitudes to working during pandemic influenza: a qualitative study. BMC Public Health, 9, 1-13.

[11] Houghton, C., Meskell, P., Delaney, H., Smalle, M., Glenton, C., & Booth, A. (2020). Barriers 664 and Facilitators to Healthcare Workers' Adherence with Infection Prevention and Control 665 (Ipc) Guidelines for Respiratory Infectious Diseases: A Rapid Qualitative Evidence 666 Synthesis. Cochrane Database Syst Rev, 4(4).

[12] Zhang, M., Zhou, M., Tang, F., Wang, Y., Nie, H., Zhang, L., & You, G. (2020). Knowledge, attitude, and practice regarding COVID-19 among healthcare workers in Henan, China. Journal of Hospital Infection, 105(2), 183-187.

[13] Edeghere, O., Fowler, T., Wilson, F., Caspa, R., Raichand, S., Kara, E., Janmohamed Rampling, S., & Olowokure, B. (2015). Knowledge, attitudes, experience and behaviour of frontline health care workers during the early phase of 2009 influenza A (H1N1) pandemic, Birmingham, UK. Journal of Health Services Research & Policy, 20(1), 26-30.14.

[14] Kollie, E. S., Winslow, B. J., Pothier, P., & Gaede, D. (2017). Deciding to work during the Ebola outbreak: the voices and experiences of nurses and midwives in Liberia. International Journal of Africa Nursing Sciences, 7, 75-81.

[15] Ashinyo, M. E., Dubik, S. D., Duti, V., Amegah, K. E., Ashinyo, A., Asare, B. A., Ackon, A. A., Akoriyea, S. K., & Kuma-Aboagye, P. (2021). Infection prevention and control compliance among exposed healthcare workers in COVID-19 treatment centers in Ghana: A descriptive cross-sectional study. Plos one, 16(3), e0248282.

[16] D’amico, F., Baumgart, D. C., Danese, S., & Peyrin-Biroulet, L. (2020). Diarrhoea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management. Clinical Gastroenterology and Hepatology, 18(8), 1663-1672.

[17] Dadras, O., Afsahi, A. M., Pashaei, Z., Mojdeganlou, H., Karimi, A., Habibi, P., Barzegary, A., Fakhfouri, A., Mirzapour, P., & Janfaza, N. (2022). The relationship between COVID‐19 viral load and disease severity: a systematic review. Immunity, inflammation and disease, 10(3), e580.

[18] Hu, Y., Sun, J., Dai, Z., Deng, H., Li, X., Huang, Q., Wu, Y., Sun, L., & Xu, Y. (2020). Prevalence and severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Journal of Clinical Virology, 127, 104371.

[19] Karia, R., Gupta, I., Khandait, H., Yadav, A., & Yadav, A. (2020). COVID-19 and its modes of transmission. SN comprehensive clinical medicine, 2(10), 1798-1801.

[20] Kavanagh, K. (2024). COVID-19 vs Seasonal Influenza: A Comparative Analysis Reveals Alarming Trends. Infection Control Today, NA-NA.

[21] Agarwal, A., Ranjan, P., Saraswat, A., Kasi, K., Bharadiya, V., Vikram, N., Singh, A., Upadhyay, A. D., Baitha, U., & Klanidhi, K. B. (2021). Are health care workers following preventive practices in the COVID-19 pandemic properly?-A cross-sectional survey from India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15(1), 69-75.

[22] Kassie, B. A., Adane, A., Abebe Kassahun, E., Ayele, A. S., & Kassahun Belew, A. (2020). Poor COVID-19 preventive practice among healthcare workers in Northwest Ethiopia, 2020. Advances in Public Health, 2020, 1-7.

[23] Raveendran, A., & Jayadevan, R. (2020). Reverse quarantine and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(5), 1323-1325.

[24] Tenforde, M. W., Patel, M. M., Ginde, A. A., Douin, D. J., Talbot, H. K., Casey, J. D., Mohr, N. M., Zepeski, A., Gaglani, M., & McNeal, T. (2022). Effectiveness of severe acute respiratory syndrome coronavirus two messenger RNA vaccines for preventing coronavirus disease 2019 hospitalizations in the United States. Clinical infectious diseases, 74(9), 1515-1524.12

Abstract:

The development process among adolescents is now increasingly changing in parallel with the development changes in the exposure of technology to that group. This causes changes to the adaptation process among adolescents including moral rehabilitation programs. Cases of drug abuse among adolescents, which are increasing day by day, require an effective moral rehabilitation program for the group to recover from the problem. Addressing drug use among adolescents is a significant concern, as it can have detrimental effects on their physical and mental health, academic performance, and overall well-being. Adolescents may experiment with drugs for various reasons, including curiosity, peer pressure, coping with stress, or seeking a sense of belonging. This study was carried out to look at the effectiveness of the rehabilitation program with a religious and spiritual concept offered at Tunas Bakti School Teluk Air Tawar, Penang as an effort to rehabilitate adolescents involved in drug abuse and to see the acceptance of the youth towards the moral rehabilitation program with a religious and spiritual concept. Data for this study has been collected using questionnaires and in-depth interviews. Quantitative data obtained from the questionnaire was analysed using the SPSS software. Based on this analysis, the effectiveness of the moral rehabilitation program is high and has a strong relationship with the youth's acceptance of the rehabilitation program carried out. The results of this study can be used to improve and improve moral rehabilitation programs for adolescents’ moral rehabilitation institutions in this country.

References:

Abstract:

While multi-drug resistant Tuberculosis (MDR-TB) remains a threat to the global fight for the elimination of Tuberculosis (TB), HIV coinfection with MDR-TB makes TB management even worse. Previous studies have reported poorer outcomes and staggering high mortality rates among persons coinfected with HIV and MDR-TB. This coinfection is said to be the leading cause of many MDR-TB-related outbreaks. However, there has been a great decline in the mortality rates reported due to the treatment of HIV with antiretroviral drugs and anti-TB drugs for MDR-TB. Coinfection of HIV and MDR-TB has high prevalence rates in certain regions of the world, including Nigeria. This study assessed the prevalence of HIV among drug-resistant TB patients attending the National Tuberculosis and Leprosy Training Centre (NTBLTC), Saye, to contribute to knowledge and data repository which is limited in this area. This cross-sectional study involved 135 GeneXpert MTB/RIF-screened patients. Blood samples for HIV testing were collected from patients who consented while sputum samples collected were analysed by GeneXpert MTB/RIF and Molecular Line Probe Assay. The results of this study showed an overall HIV prevalence rate of 35.6% (p<0.05) among GeneXPert MTB/RIF-positive confirmed TB subjects.HIV incidence rates among different drug-resistant groups were as follows; mono-resistant TB 19(14.1%), MDR-TB 16(11.9%) and Poly-resistance was determined to be 2 (1.5%) respectively.

References:

[1] World Health Organization, 2015, (Guidelines on the management of latent tuberculosis infection), Date of access: 1 January 2015, Available from: https://www.who.int/publications/i/item/9789241548908.

[2] World Health Organization (Global Tuberculosis Report, 2014), Date of access: 23 October 2014, Available from: http://www.who.int/tb/publications/global_report/en/.

[3] DeCock, K.M., Soro, B., Coulibaly, I.M., and Lucas, S.B., 1992, Tuberculosis and HIV infection in sub-Saharan Africa. JAMA, 268:1581–1587. DOI:10.1001/jama.268.12.1581.

[4] Alikor, D. E. and Erhabor, N. O. 2006, “Trend of HIV- seropositivity among children in tertiary health institution in the Niger Delta Region of Nigeria,” Afr. J. Health Sci. 13(1-2), 80-85. DOI: 10.4314/ajhs.v13i1.30820.

[5] Muhammad, K. M., Sana, R., Muhammad, A., Rizwan, I., Saqib, S., 2015, Comparison of Ziehl Neelsen Microscopy with GeneXpert for Detection of Mycobacterium Tuberculosis. Journal of Dental and Medical Sciences,14(11),56 -60.https//www.iosrjournals.org.

[6] Theron, G., Peter, J., van Zyl-Smit, R., Mishra, H., Streicher, E., Murray, S., Dheda, K., 2011. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. American journal of Respiratory and Critical Care medicine 18(1).132-40. doi:10.1164/reem.201101-0056OC.

[7] Federal Ministry of Health, Federal Republic of Nigeria (Report: First National TB Prevalence Survey 2012, Nigeria), Date of access August; 2012. https://www.health.gov.ng/doc/First%20National%20TB%20Prevalence%20Survey%20Report.pdf

[8] World Health Organisation (Global Tuberculosis Report 2015), Date of access: 28 Oct 2015. www.who.Intltb/publications/global report.

[9] Boehme C.C., Nabeta P, Hillemann D., Nicol M.P., Shenai S., Krapp F., Allen J., Tahirli R., Blakemore R., Rustomjee R., Milovic A., Jones M., O'Brien S.M., Persing D.H., Ruesch-Gerdes S., Gotuzzo E., Rodrigues C., Alland D., Perkins MD., 2010, Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med.,363(11):1005-15. doi: 10.1056/NEJMoa0907847.

[10] Hain Lifescience (GenoType MTBDRplus VER 2.0.) 2019, Identification of the M. tuberculosis complex and its resistance to Rifampicin and/or Isoniazid from pulmonary clinical specimens or cultivated samples.https://www.hain-lifescience.de/en/products/microbiology/mycobacteria/tuberculosis/genotype mtbdrplus.html.

[11] Federal Ministry of Health 2021, National AIDS and STDs Control Programme. National Guidelines for HIV prevention treatment and care. https://nascp.gov.ng.

[12] Singh A., Prasad R., Balasubramanian V., Gupta N., 2020, Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives. HIV AIDS (Auckl),12:9-31. doi: 10.2147/HIV.S193059.

[13] Ugwu K.O., Agbo M. C., Ezeonu I. M., 2021, prevalence of tuberculosis, drug-resistant tuberculosis and hiv/tb co-infection in enugu, nigeria. Afr J Infect Dis. 15(2):24-30. doi: 10.21010/ajid.v15i2.5.

[14] Aminu A.I., Tukur A.D., 2016, Detection of multidrug resistant tuberculosis (MDR-TB) among rifampicin-resistant TB patients using line probe assay (LPA) in Kano, Nigeria, Bayero J. Pure Appl. Sci. 9 (2):1–8, https://doi.org/10.4314/bajopas.v9i2.1.

[15] Kolade O. R., Atilola O.G., Babalola T.V., Komolafe O.I., 2016, Prevalence of HIV infection among tuberculosis patients in a teaching hospital in South-West Nigeria: A four-year retrospective study, science Direct HIV & AIDS Review, 15,(4),136 - 140. https://doi.org/10.1016/j.hivar.2016.11.001.

[16] Oladeinde B.H., Olley M., Imade O.S., Onifade A.A., 2014. Prevalence of HIV infection among patients with pulmonary tuberculosis in a rural tertiary hospital in Nigeria. Niger J Exp Clin Biosci. 2:90-4. http://www.njecbonline.org.

[17] Adejumo O.A., Daniel O.J., Otesanya A.F., Adegbola A.A., Femi-Adebayo T., Bowale A., Adesola S., Kuku O.O., Otemuyiwa K.O., Oladega S.N., Johnson E.O., Falana A.A., Dawodu O., Owuna H., Osoba G., Dacosta A., 2017, Factors associated with tb/hiv co-infection among drug sensitive tuberculosis patients managed in a secondary health facility in lagos, nigeria. Afr J Infect Dis.11(2):75-82. doi: 10.21010/ajid.v11i2.10.

[18] Awoyemi O.B., Ige O.M., Onadeko B.O., 2002, Prevalence of active pulmonary tuberculosis in human immunodeficiency virus seropositive adult patients in University College Hospital, Ibadan, Nigeria. Afr J Med Med Sci. 31(4):329-32. https://pubmed.ncbi.nlm.nih.gov/15027773/.

[19] Egbe K., Ike A. C., Aleruchi C., 2016. Prevalence of Tuberculosis and Rifampicin Resistance Among Patients Seeking Medical Care in Nasarawa State, North Central Nigeria. Science Journal of Public Health, 4(3), 214-218. https://doi.org/10.11648/j.sjph.20160403.18

[20] Daniel O. J., Alausa O. K., 2006. Treatment outcome of TB/HIV positive and TB/HIV negative patients on directly observed treatment, short course (DOTS) in Sagamu, Nigeria. Niger J Med.,15(3): 222-6.doi: 10.4314/njm.v15i3.37217.

[21] Deivanayagam C.N., Rajasekaran S., Venkatesan R., Mahilmaran A., Ahmed P.R., Annadurai S., Kumar S., Chandrasekar C., Ravichandran N., Pencillaiah R., 2002, Prevalence of acquired MDR-TB and HIV co-infection. Indian J Chest Dis Allied Sci. 44(4):237-42. https://pubmed.ncbi.nlm.nih.gov/12437236/.

[22] United States Government agency for international development (The Twin epidemics: HIV and TB coinfection). https://2012-2017.usaid.gov/news-information/fact-sheets/twin-epidemics-hiv-and-tb-co-infection, Date accessed: June 2012 to September 2017.

[23] Gunda D.W., Maganga S.C., Nkandala I., Kilonzo S.B., Mpondo B.C., Shao E.R., Kalluvya S.E., 2018. Prevalence and Risk Factors of Active TB among Adult HIV Patients Receiving ART in Northwestern Tanzania: A Retrospective Cohort Study. Can J Infect Dis Med Microbiol. 4;2018:1346104. doi: 10.1155/2018/1346104.

[24] Kapata N., Chanda-Kapata P., Michelo C., 2013, The social determinants of tuberculosis and their association with TB/HIV co-infection in Lusaka, Zambia. Medical Journal of Zambia, 40 (2). https://www.ajol.info/index.php/mjz/article/view/110518.

[25] World Health Organization (Global Tuberculosis Report 2019), Date of access: 17 Oct. 2019. https://www.who.int/tb/publications/global_report/en/.

[26] Selwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H., 1989. A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection. New England Journal of Medicine, 320(9), 545-550. https://doi.org/10.1056/NEJM198903023200901.

[27] Oshi, D.C., Oshi, S.N., Alobu, I., and Ukwaja, K.N., 2014, Profile, Outcomes, and Determinants of Unsuccessful Tuberculosis Treatment Outcomes among HIV-Infected Tuberculosis Patients in a Nigerian State. Tuberc Res Treat, http://dx.doi.org/10.1155/2014/202983.

[28] Njoku, A.K., 2005, Tuberculosis: Current Trends in Diagnosis and Treatment. Nigerian Journal of Clinical Practice, 8(2), 118-124.

[29] World Health Organization (who engages over 12,000 community informants fast-track efforts in finding ‘missing TB cases), Date of access:23/03/2019.https://www.afro.who.int/news/who-engages-over-12000-community-informants-fast-track-efforts-finding-missing-tb-cases.

[30] Oladimeji, O., Atiba, B. P., Anyiam, F.E., Odugbemi, B. A., Afolaranmi, T., Zoakah, A. I., Horsburgh, C.R., 2023, Gender and Drug-Resistant Tuberculosis in Nigeria. Trop. Med. Infect. Dis., 8, 104. https://doi.org/10.3390/tropicalmed8020104.

Abstract:

Patient satisfaction is a useful measure in assessing the quality of health care service received by patients. Patient satisfaction may influence healthcare utilization and can be a predictor of subsequent health-related behaviour regarding patients’ willingness to recommend their healthcare provider(s). This study therefore evaluated patient satisfaction with the National Health Insurance Scheme (NHIS) among accredited private hospitals in Ado-Ekiti, Ekiti state, South West Nigeria, as many earlier studies focused primarily on clients attending government-owned hospitals. A descriptive cross-sectional study among enrollees of NHIS-accredited private hospitals in Ado-Ekiti between July and September 2023 with the use of a semi-structured questionnaire. A multi-stage sampling technique was used to select respondents for the study. Data was analyzed using SPSS version 25. Both descriptive and inferential statistics were carried out and the level of significance was taken at P<0.05. A total of 316 were included in the study. The majority were married (85.2%), in secondary education (48.1%), and registered on government-organized care (67.1%), female respondents (52.2%) were more than male respondents (47.8%). About 89.9% of respondents were willing to re-use the facility and recommend the health-care scheme to a friend. About 70.6% of respondents scored high (>60%) on patient satisfaction with mean satisfaction score±(SD) of 71.3±16.4. Identified predictors of patient satisfaction include female sex, having tertiary education, and belonging to government-organized care as a type of health insurance. The study concluded that the majority of the registered patients were satisfied with the services at NHIS-accredited private hospitals and were willing to recommend the health facility.

References:

Abstract:

The Gambia Malaria Strategy Plan 2021 – 2025 places greater emphasis on strategies for malaria elimination. Hence, North Bank Regions (NBR) have been identified due to the relative low transmission to introduce case-based surveillance as a strategy for malaria elimination. Social Behaviour Change Communication (SBCC) is a critical component of the malaria program. SBCC study in NBR would provide evidence essential for malaria elimination. A three-stage cluster sampling design was used, and the NBR were purposely targeted due to their relative low malaria transmission. In total, 167 household heads and 192 caregivers of children under five years were interviewed. The findings showed that over 90% in NBR valued the use of Long-Lasting Insecticidal Nets (LLIN) in preventing malaria even if it differed in shape and texture from their taste. It is evident that use of health centre/hospital, radio and community health worker can engender wider coverage of messages on malaria in NBR. Malaria treatment was sought and received in a timely manner. Most respondents treated for malaria were tested for malaria prior to the treatment. Overall results are indicative of high levels of knowledge and practice in the prevention, control and treatment of malaria. Despite the existence of few misconceptions and resistance to change that limits the gains made through concerted efforts. The findings are indicative of room for improvement for the achievement of more effective malaria prevention and treatment. Additionally, affordability of LLINs featured prominently, whereas free net distribution could significantly increase access, the issue of sustainability remains pertinent.

References:

Abstract:

The COVID-19 pandemic has posed unprecedented challenges to the education sector worldwide, particularly affecting students' access to learning. This study investigated the level of students' access to education during and after the pandemic at St. Martin Primary School, Mulago, Kampala, Uganda. Socio-economic and school-related factors influencing access to education are examined, along with the implications of these challenges on clinical practice. A cross-sectional survey was conducted among students at St. Martin Primary School, Mulago, Kampala, Uganda, utilizing both quantitative and qualitative methods using structured questionnaires and key informant interview guides respectively. Purposive, snowball and systematic random sampling techniques were utilized. Data was collected from 108 students in Primary seven on students' access to education, socio-economic challenges, and school-related factors. Chi-square tests were employed to analyze associations between variables. The study revealed that 88.0% of students reported having access to education during the pandemic, primarily through online classes (93.7%). Socio-economic challenges, including parental education level, household income sources, and loss of family income due to the pandemic, significantly impacted access to education. School-related challenges, such as dissatisfaction with communication from school, lack of clear instructions for online classes, and encountering technical issues, also hindered access. Significant associations between socio-economic factors, school-related challenges, and access to education were identified. There is need for Policy interventions to focus on bridging the digital divide, providing support for vulnerable households.

References:

[1].   Wang, C., et al., 2020, A novel Coronavirus Outbreak of Global Health Concern. The Lancet, 395(10223): p. 470-473.

[2].   Gong, F., et al., 2020, China’s Local Governments are Combating COVID-19 with Unprecedented Responses—From A Wenzhou Governance Perspective. Frontiers of Medicine, p. 1-5.

[3].   Coe, P. F., L. L. Graper, and C. M. Zangerle, 2020, Leading Through the Unknown: A Network Perspective of the COVID-19 Pandemic. Critical Care Nursing Quarterly, 43(4): p. 451-467.

[4].   UNESCO Education: From COVID-19 School Closures To Recovery. 2020.

[5].   European Union Policy measures to Monitor And Mitigate The Negative Impacts of COVID-19 and COVID-19 Related Policy Measures On Education. 2021.

[6].   Fahle, E.M., et al., 2020, Racial Segregation and School Poverty in the United States, 1999–2016. Race and Social Problems, 12: p. 42-56.

[7].   Balakrishnan, P., 2020, Education in the Age of COVID-19: Educational Responses from Four Southeast Asian Countries. in ISEA.

[8].   Adarkwah, M., 2021, An Outbreak of Online Learning in the COVID-19 Outbreak in Sub- Saharan Africa: Prospects and Challenges. Global Journal of Computer Science and Technology, 21: p. 1-10.

[9].   UNICEF The Impacts of COVID-19 on Education Spending in Africa and Possible Recovery Pathways. 2022.

[10].  Gustafsson, M., 2021, Pandemic-Related Disruptions to Schooling and Impacts on Learning Proficiency Indicators: A Focus on the Early Grades. UNESCO Institute for Statistics, 14.

[11].  Zar, H. J., et al., 2020, Challenges of COVID-19 in Children in Low- And Middle-Income Countries. Paediatr Respir Rev, 35: p. 70-74.

[12].  Okaka, W., The Impact of COVID-19 on Education System in Uganda. 2020.

[13].  Etomes, S. E., Challenges Faced by Students During the COVID-19 Lockdown: Rethinking the Governance of Higher Education in Cameroon. Journal of Education and Learning, 2022. 11(6): p. 27-40.

[14].  Salakhova, V. B., et al., 2022, The Problems of the COVID-19 Pandemic in Higher Education. in Frontiers in Education. Frontiers.

[15].  Ministry of Education and Sports, Education and Sports Sector Digital Agenda Stakeholder Engagement Report. 2021.

[16].  Lordan, R., et al., 2021, Considerations for the Safe Operation of Schools During the Coronavirus Pandemic. Frontiers in Public Health, 9: p. 751451.

[17].  Krejcie, R. and D. Morgan, 1970, Determining Sample Size For Research Activities. Educational and Psychological Measurement, 30(3): p. 607-610.

[18].  Wabukala, B. M., et al., 2022, Unbundling Barriers to Electricity Security in Uganda: A Review. Energy Strategy Reviews, 44: p. 100984.

[19].  Parolin, Z., 2020, Unemployment and Child Health During COVID-19 in the USA. The Lancet Public Health, 5(10): p. e521-e522.

[20].  Santos, S., et al., 2021, Case Report: Parental Loss and Childhood Grief during COVID-19 pandemic. Frontiers in Psychiatry, 12: p. 626940.

[21].  Ogundari, K., Student Access to Technology at Home and Learning Hours During COVID-19 in the U.S. 2023: p. 1-18.

[22].  Yoon, Y., et al., Stepwise School Opening and an Impact on The Epidemiology of COVID-19 in the Children. Journal of Korean Medical Science, 2020. 35(46).

[23].  Browne, N. T., et al., 2021, When Pandemics Collide: The Impact of COVID-19 on Childhood Obesity. Journal of Pediatric Nursing, 56: p. 90.

[24].  McKenzie, K., Murray, G. C., and Martin, R., 2021, ‘It's been Adapted Rather Than Impacted’: A Qualitative Evaluation of the Impact of Covid‐19 Restrictions on the Positive Behavioural Support of People with an Intellectual Disability and/or Autism. Journal of Applied Research in Intellectual Disabilities, 34(4): p. 1089-1097.

Abstract:

Pesticides are essential in agriculture and public health, but their use is associated with many adverse health outcomes. The objective of the current study was to review published case reports to elucidate the pattern and health impacts of exposure to various pesticide classes, including organochlorines, organophosphates, carbamates, pyrethroids, organosulfur, botanicals, and biopesticides. We conducted a review of case reports focusing on the health effects of pesticide exposure across different chemical classes. Searches were performed in major scientific databases, and relevant articles were selected based on predetermined inclusion criteria. Data extraction and synthesis were carried out to identify common health outcomes associated with each pesticide class. Organochlorines, despite being largely phased out, still pose risks due to their persistence and bioaccumulation, with links to neurodegenerative diseases and cancer. Organophosphates, known for cholinergic overstimulation, can lead to respiratory distress and seizures. Carbamates, affecting cholinesterase activity, may cause respiratory paralysis and coma. Pyrethroids disrupt the nervous system and can induce convulsions and alter consciousness. Organosulfur can induce liver damage and renal dysfunction. Botanical pesticides and biopesticides, while generally considered safer, can also cause severe toxicity, including methemoglobinemia and multiorgan failure, as evidenced by rare cases of poisoning. This review highlights the diverse health impacts of pesticide exposure across different chemical classes. It exposes the need for systematic surveillance, longitudinal studies, and comparative assessments between conventional pesticides and biopesticides. Interdisciplinary collaborations are crucial for comprehensive risk assessment and the development of targeted interventions to mitigate these detrimental effects.

References:

[1].   Kalyabina, V. P., Esimbekova, E. N., Kopylova, K. V., & Kratasyuk, V. A. (2021). Pesticides: Formulants, Distribution Pathways and Effects on Human Health–A Review. Toxicology Reports, 8, 1179-1192. Doi:10.1016/j.toxrep.2021.06.004.

[2].   Abubakar, Y., Tijjani, H., Egbuna, C., Adetunji, C. O., Kala, S., Kryeziu, T. L., et al. (2020). Pesticides, history, and classification. In H. Tijjani, C. Egbuna, & S. Kala (Eds.), Natural Remedies for Pest, Disease and Weed Control (pp. 29-42). Academic Press. Doi:10.1016/B978-0-12-819304-4.00003-8.

[3].   Leoci, R., & Ruberti, M. (2021). Pesticides: An Overview of the Current Health Problems of their Use. Journal of Geosciences and Environment Protection, 9(8), 1-20. Doi:10.4236/gep.2021.98001.

[4].   Leemans, M., Couderq, S., Demeneix, B., & Fini, J. B. (2019). Pesticides with Potential Thyroid Hormone-Disrupting Effects: A Review of Recent Data. Frontiers in Endocrinology, 10, 468622. Doi:10.3389/fendo.2019.00743.

[5].   Moebus, S., & Boedeker, W. (2021). Case Fatality as an Indicator for the Human Toxicity of Pesticides—A Systematic Scoping Review on the Availability and Variability of Severity Indicators of Pesticide Poisoning. International Journal of Environmental Research and Public Health, 18(16), 8307. Doi:10.3390/ijerph18168307.

[6].   Duke, S. O. (2023). Dihydroorotate Dehydrogenase as an Herbicide Target. Proceedings of the National Academy of Sciences, 120(51), e2319097120. Doi:10.1073/pnas.2319097120.

[7].   Zikankuba, V. L., Mwanyika, G., Ntwenya, J. E., & James, A. (2019). Pesticide Regulations and their Malpractice Implications on Food and Environment Safety. Cogent Food & Agriculture, 5(1), 1601544. Doi:10.1080/23311932.2019.1601544.

[8].   Shi, L. L., Shan, Z. J., Kong, D. Y., & Cai, D. J. (2006). The Health and Ecological Impacts of Organochlorine Pesticide Pollution in China: Bioaccumulation of Organochlorine Pesticides in Human and Fish Fats. Human Ecology Risk Assessment, 12(2), 402-407. Doi:10.1080/10807030500536843.

[9].   Chopra, A. K., Sharma, M. K., & Chamoli, S. (2011). Bioaccumulation of Organochlorine Pesticides in Aquatic System—An Overview. Environmental Monitoring and Assessment, 173, 905-916. Doi:10.1007/s10661-010-1433-4.

[10].  Taiwo, A. M. (2019). A Review of Environmental and Health Effects of Organochlorine Pesticide Residues in Africa. Chemosphere, 220, 1126-1140. Doi:10.1016/j.chemosphere.2019.01.001.

[11].  Singh, Z., Kaur, J., Kaur, R., & Hundal, S. S. (2016). Toxic Effects of Organochlorine Pesticides: A Review. American Journal of BioScience, 4(3), 11. Doi:10.11648/j.ajbio.s.2016040301.13.

[12].  Arora, S. K., Batra, P., Sharma, T., Banerjee, B. D., & Gupta, S. (2013). Role of Organochlorine Pesticides in Children with Idiopathic Seizures. International Scholarly Research Notices. Doi:10.1155/2013/849709

[13].  Pattnaik, M., Pany, B. K., Dena, J., Pal, A. K., & Sahu, G. (2020). Effect of Organochlorine Pesticides on Living Organisms and Environment. Chemical Science Review Letters, 9, 682-686. Doi:10.37273/chesci.CS2051063.

[14].  Ozucelik, D. N., Karcioglu, O., Topacoglu, H., & Fowler, J. R. (2004). Toxicity Following Unintentional DDT Ingestion. Journal of Toxicology and Clinical Toxicology, 42(3), 299-303. Doi:10.1081/CLT-120037432.

[15].  Kucuker, H., Sahin, O., Yavuz, Y., & Yürümez, Y. (2009). Fatal Acute Endosulfan Toxicity: A Case Report. Basic & Clinical Pharmacology & Toxicology, 104(1), 49-51. Doi:10.1111/j.1742-7843.2008.00216.x.

[16].  Parbhu, B., Rodgers, G., & Sullivan, J. E. (2009). Death in a Toddler Following Endosulfan Ingestion. Clinical Toxicology, 47(9), 899-901. Doi:10.3109/15563650903328879.

[17].  Sidhu, G. K., Singh, S., Kumar, V., Dhanjal, D. S., Datta, S., & Singh, J. (2019). Toxicity, Monitoring and Biodegradation of Organophosphate Pesticides: A Review. Critical Reviews in Environmental Science and Technology, 49(13), 1135-1187. Doi:10.1080/10643389.2019.1565554.

[18].  Peter, J. V., Sudarsan, T. I., & Moran, J. L. (2014). Clinical Features of Organophosphate Poisoning: A Review of Different Classification Systems and Approaches. Indian Journal of Critical Care Medicine, 18(11), 735. Doi:10.4103/0972-5229.144017.

[19].  Robb, E. L., Regina, A. C., & Baker, M. B. Organophosphate Toxicity. PMID: 29261901.

[20].  Chua, J. J. L., & Kuan, K. K. (2022). Organophosphate Poisoning From Inappropriate Topical Use of Malathion Pesticide: A Case Report. Proceedings Singapore Healthcare, 31, 20101058211068593. Doi:10.1177/20101058211068593.

[21].  Solomon, G. M., & Moodley, J. (2007). Acute Chlorpyrifos Poisoning in Pregnancy: A Case Report. Clinical Toxicology, 45(4), 416-419. Doi:10.1080/15563650601117988.

[22].  Kidiyoor, Y., Nayak, V. C., Devi, V., Bakkannavar, S. M., Kumar, G. P., & Menezes, R. G. (2009). A Rare Case of Myocardial Infarction due to Parathion Poisoning. Journal of Forensic and Legal Medicine, 16(8), 472-474. Doi:10.1016/j.jflm.2009.05.003.

[23].  Isbister, G. K., Mills, K., Friberg, L. E., Hodge, M., O'Connor, E., Patel, R., et al. (2007). Human Methyl Parathion Poisoning. Clinical Toxicology, 45(8), 956-960. Doi:10.1080/15563650701232745.

[24].  Gupta, R. C., Malik, J. K., & Milatovic, D. (2011). Organophosphate and Carbamate Pesticides. In Reproductive and Developmental Toxicology. Academic Press. Doi:10.1016/B978-0-12-382032-7.10037-2.

[25].  Silberman, J., & Taylor, A. Carbamate Toxicity. PMID: 29489157

[26].  Klatka, B. Z., Terpilowski, M., Orzel, A. K., Janeczko, D., Holowczuk, M., Tchórz, M., et al. (2021). Severe Carbamates Intoxication of 43-year-old Farmer-Case Report. Annals of Agricultural and Environmental Medicine, 28(2). doi:10.26444/aaem/121067

[27].  El-Nahhal, Y. (2018). Successful Management of Carbamate Poisoning Among Children: Case Report from Gaza Strip. Occupational Diseases and Environmental Medicine, 6(3), 95-106. Doi:10.4236/odem.2018.63008.

[28].  Lenski, M., Letrillart, A., Gish, A., Nisse, P., Gaulier, J. M., & Allorge, D. (2022). Aldicarb-related Suicide Attempt Cases in North of France (2012–2021). Toxicology Research, 11(3), 529-536. Doi:10.1093/toxres/tfac031.

[29].  Bhardwaj, K., Sharma, R., Abraham, J., & Sharma, P. (2020). Pyrethroids: A Natural Product for Crop Protection. In Natural Bioactive Products in Sustainable Agriculture. Academic Press. Doi:10.1007/978-981-15-3024-1_8.

[30].  Bradberry, S. M., Cage, S. A., Proudfoot, A. T., & Vale, J. A. (2005). Poisoning due to Pyrethroids. Toxicological Reviews, 24, 93-106. Doi:10.2165/00139709-200524020-00003.

[31].  Ramchandra, A. M., Chacko, B., & Victor, P. J. (2019). Pyrethroid Poisoning. Indian Journal of Critical Care Medicine. Doi:10.5005/jp-journals-10071-23304.

[32].  Scheepers, L. D., Freercks, R., & van der Merwe, E. (2023). Acute Cypermethrin and Other Pyrethroid Poisoning–An Organophosphate-Like Poisoning: A Case Report and Review. Toxicology Reports, 11, 107-110. Doi:10.1016/j.toxrep.2023.06.013.

[33].  Aggarwal, P., Jamshed, N., Ekka, M., & Imran, A. (2015). Suicidal Poisoning with Cypermethrin: A Clinical Dilemma in the Emergency Department. Journal of Emergencies, Trauma, and Shock, 8(2), 123-125. Doi:10.4103/0974-2700.145424.

[34].  Atashi, H. A., Arani, H. Z., Ghorani, S. M., Khorasani, M. S. T., & Moalem, M. (2022). Cardiac and Respiratory Arrest in a 12-Year-Old Girl with Acute Permethrin Toxicity: A Case Report. Doi:10.21203/rs.3.rs-305921/v2.

[35].  Araújo, M. F., Castanheira, E. M., & Sousa, S. F. (2023). The Buzz on Insecticides: A Review of Uses, Molecular Structures, Targets, Adverse Effects, and Alternatives. Molecules, 28(8), 3641. Doi:10.3390/molecules28083641.

[36].  Huang, X., Zhang, C., Hu, R., Li, Y., Yin, Y., Chen, Z., et al. (2016). Association Between Occupational Exposures to Pesticides with Heterogeneous Chemical Structures and Farmer Health in China. Scientific Reports, 6(1), 25190. Doi: 10.1038/srep25190.

[37].  Zakharov, S., Csomor, J., Urbanek, P., & Pelclova, D. (2016). Toxic Epidermal Necrolysis After Exposure to Dithiocarbamate Fungicide Mancozeb. Basic & Clinical Pharmacology & Toxicology, 118(1), 87-91. https://doi.org/10.1038/srep25190

[38].  Romoli, J. C., Scarferla, D. T. P., Aguera, R. G., Lini, R. S., Pante, G. C., Bueno Junior, C. R., et al. (2022). Analytical and Toxicological Aspects of Dithiocarbamates: An Overview of the Last 10 Years. Toxicology Mechanisms and Methods, 32(9), 637-649. https://doi.org/10.1080/15376516.2022.2063096

[39].  El-Wakeil, N. E. (2013). Botanical Pesticides and Their Mode of Action. Gesunde Pflanzen, 65(4). https://doi.org/10.1007/s10343-013-0308-3

[40].  Ngegba, P. M., Cui, G., Khalid, M. Z., & Zhong, G. (2022). Use of Botanical Pesticides in Agriculture as an Alternative to Synthetic Pesticides. Agriculture, 12(5), 600. https://doi.org/10.3390/agriculture12050600

[41].  Wood, D. M., Alsahaf, H., Streete, P., Dargan, P. I., & Jones, A. L. (2005). Fatality After Deliberate Ingestion of the Pesticide Rotenone: A Case Report. Critical Care, 9, 1-5. https://doi.org/10.1186/cc3528

[42].  Gupta, P., & Verma, P. K. (2020). A Rare Cause of Methemoglobinemia: How Safe are So-called Biopesticide? Indian Journal of Critical Care Medicine, 24(3), 208. https://doi.org/10.5005/jp-journals-10071-23373

[43].  Amrollahi-Sharifabadi, M., Seghatoleslami, A., Amrollahi-Sharifabadi, M., Bayani, F., & Mirjalili, M. (2013). Fatal Colchicine Poisoning by Accidental Ingestion of Colchicum Persicum: A Case Report. American Journal of Forensic Medicine & Pathology, 34(4), 295-298. https://doi.org/10.1097/PAF.0000000000000059

[44].  Sahayaraj, K., & Hassan, E. (2023). Biocompatibility of Biopesticides with Predatory Insects. in Worldwide Predatory Insects in Agroecosystems (pp. 785-820). Singapore: Springer Nature Singapore. https://doi.org/10.1007/978-981-99-1000-7_21

[45].  Egbuna, C., Sawicka, B., Tijjani, H., Kryeziu, T. L., Ifemeje, J. C., Skiba, D., et al. (2020). Biopesticides, Safety Issues and Market Trends. In Natural Remedies for Pest, Disease and Weed Control (pp. 43-53). Academic Press. https://doi.org/10.1016/B978-0-12-819304-4.00004-X

[46].  Then, C., & Bauer-Panskus, A. (2017). Possible Health Impacts of Bt Toxins and Residues from Spraying with Complementary Herbicides in Genetically Engineered Soybeans and Risk Assessment as Performed by the European Food Safety Authority EFSA. Environmental Sciences Europe, 29, 1-11. https://doi.org/10.1186/s12302-016-0099-0

[47].  Santos, V. S. V., & Pereira, B. B. (2020). Properties, Toxicity and Current Applications of The Biolarvicide Spinosad. Journal of Toxicology and Environmental Health, Part B, 23(1), 13-26. https://doi.org/10.1080/10937404.2019.1689878

[48].  Su, T. Y., Lin, J. L., Lin-Tan, D. T., Tseng, H. H., & Yen, T. H. (2011). Human Poisoning with Spinosad and Flonicamid Insecticides. Human & Experimental Toxicology, 30(11), 1878-1881. https://doi.org/10.1177/09603271114016

[49].  Zaynab, M., Fatima, M., Sharif, Y., Sughra, K., Sajid, M., Khan, K. A., . & Li, S. (2021). Health and Environmental Effects of Silent Killers Organochlorine Pesticides and Polychlorinated Biphenyl. Journal of King Saud University-Science, 33(6), 101511. https://doi.org/10.1016/j.jksus.2021.101511

[50].  Calle, E. E., Frumkin, H., Henley, S. J., Savitz, D. A., & Thun, M. J. (2002). Organochlorines and Breast Cancer Risk. CA: A Cancer Journal for Clinicians, 52(5), 301-309. https://doi.org/10.3322/canjclin.52.5.301

[51].  King, A. M., & Aaron, C. K. (2015). Organophosphate and Carbamate Poisoning. Emergency Medicine Clinics, 33(1), 133-151. https://doi.org/10.1016/j.emc.2014.09.010

[52].  Gupta, R. C., & Milatovic, D. (2012). Toxicity of Organophosphates and Carbamates. https://doi.org/10.1039/9781849733007-00104

[53].  Martín Reina, J., Duarte, J. A., Cerrillos, L., Bautista Palomas, J. D., & Moreno Navarro, I. M. (2017). Insecticide Reproductive Toxicity Profile: Organophosphate, Carbamate and Pyrethroids. Journal of Toxins, 4 (1), 1-7.

[54].  Abdollahi, M., Ranjbar, A., Shadnia, S., Nikfar, S., & Rezaie, A. (2004). Pesticides and Oxidative Stress: A Review. Med Sci Monit, 10(6), 141-147.

[55].  Eskenazi, B., Bradman, A., & Castorina, R. (1999). Exposures of Children to Organophosphate Pesticides and their Potential Adverse Health Effects. Environmental Health Perspectives, 107(suppl 3), 409-419. https://doi.org/10.1289/ehp.99107s3409

[56].  Khursheed, A., Rather, M. A., Jain, V., Rasool, S., Nazir, R., Malik, N. A., & Majid, S. A. (2022). Plant Based Natural Products aas Potential Ecofriendly and Safer Biopesticides: A Comprehensive Overview of their Advantages Over Conventional Pesticides, Limitations and Regulatory Aspects. Microbial Pathogenesis, 173, 105854. https://doi.org/10.1016/j.micpath.2022.105854

Abstract:

This paper is based on operational research conducted in Benghazi, eastern Libya. The study assessed the feasibility of a cross-sectoral integrated services delivery strategy for vulnerable children, primarily migrants, refugees, and internally displaced families. These groups are often deprived of their basic rights to health, education, and protection services. Future Makers, a civil society organization in East Libya, implemented the project with support from UNICEF, international NGOs, and technical experts from UNICEF. Libya’s political, geographic, and economic context has made it a hub for those escaping conflict and poverty. However, the country faces numerous challenges, including political instability, human rights violations, and inadequate support for migrants and refugees. The Baity Center, meaning “My Home” in Arabic, is a strategic approach to providing services to these vulnerable children under one roof. This approach was implemented for the first time in East Libya. The Future Makers team completed the first year of the project, delivering services to more than 700 children who needed any of these services. They extended their mental health and psychosocial support (MHPSS) services to families in cases of gender-based violence and mental health issues for parents, particularly mothers, and young siblings. The paper discusses the challenges faced by young migrant children and the restrictive policies in Libya that hinder their access to basic rights and effectiveness of Baity Center to address this. The acceptance of the Baity Center and the high demand for its services were reflected by high levels of utilization and requests for its continuity met by extended donor support.

References:

[1].   Baldwin‐Edwards, M., & Lutterbeck, D. (2018). Coping with the Libyan Migration Crisis. Journal of Ethnic and Migration Studies, 45(12), 2241–2257. https://doi.org/10.1080/1369183x.2018.1468391

[2].   Paoletti, E. (2011). Migration and Foreign Policy: The case of Libya. Journal of North African Studies, 16(2), 215–231. https://doi.org/10.1080/13629387.2011.532588

[3].   Zwick, H. S. (2022). Onward Migration Aspirations and Destination Preferences of Refugees and Migrants in Libya: The Role of Persecution and Protection Incidents. Journal of Ethnic and Migration Studies, 48(15), 3705–3724. https://doi.org/10.1080/1369183x.2022.2031923

[4].   International Organization for Migration. (2021, August 16). DTM Libya — Migrant Report 37 (May-June 2021). IOM, Libya. https://dtm.iom.int/reports/libya-%E2%80%94-migrant-report-37-may-june 2021#:~:text=DTM%20Libya%20identified%20a%20total%20of%20597%2C611%20migrants,round%20of%20data%20collection%20%28March%20and%20April%202021%29

[5].   Phillips, M. (2022). Advocates, Implementers or Allies? NGOs between Humanitarian Borderwork and Migration Management in Libya. Journal of Intercultural Studies, 44(1), 110–124. https://doi.org/10.1080/07256868.2022.2159937

[6].   Fowler, G. L., Cordell, D. D., Buru, M. M., Barbour, N., & Brown, L. C. (2024, May 10). Libya | History, People, Map, & Government. Encyclopedia Britannica. https://www.britannica.com/place/Libya

[7].   REACH. (2021). Migrants and refugees in Libya: 2021 MSNA Bulletin Key Findings (November 2021). https://repository.impact-initiatives.org/document/reach/19ae4f9c/REACH_LBY_Bulletin_2105b_2022.pdf

[8].   REACH. (2022). Libyan Population Multi-Sector Needs Assessment 2021. https://repository.impact-initiatives.org/document/reach/d2fc02ac/REACH_LBY_report_LBY2105a_May2022.pdf

[9].   WHO Libya: Health Response to COVID-19 in Libya, update # 30 (Reporting period: 1-31 August 2021) - Libya. (2021, September 5). ReliefWeb. https://reliefweb.int/report/libya/who-libya-health-response-covid-19-libya-update-30-reporting-period-1-31-august-2021

[10].  Libya: Asylum seekers, refugees need crisis response. (2021, November 4). Human Rights Watch. https://www.hrw.org/news/2021/11/03/libya-asylum-seekers-refugees-need-crisis-response

[11].  Gluck, C., & Alalem, M. (2020, January 28). The challenge of helping child refugees in Libya overcome trauma. UNHCR. https://www.unhcr.org/news/stories/challenge-helping-child-refugees-libya-overcome-trauma

[12].  UNHCR - The UN Refugee Agency. (1967). Convention and Protocol Relating to the Status of Refugees | UNHCR. UNHCR. https://www.unhcr.org/media/convention-and-protocol-relating-status-refugees

[13].  Libya - Refugees and Asylum Seekers In Urban Areas. (2017). Global Focus. https://reporting.unhcr.org/libya-refugees-and-asylum-seekers-urban-areas-5

[14].  Libya and Malta: Failing Refugees, Asylum-Seekers and Migrants. (2020, December 14). Amnesty International. https://www.amnesty.org/en/wp-content/uploads/2023/08/pre014152010en.pdf.

[15].  Libya: Derna Flood Response Costs Lives. (2023, December 6). Human Rights Watch. https://www.hrw.org/news/2023/12/06/libya-derna-flood-response-costs-lives

Abstract:

This study explored healthcare providers' perceptions of the National Guidelines for Diagnosis and Treatment of Malaria (NGDTM) in Benue State, Nigeria, focusing on adherence barriers and facilitators. Employing a cross-sectional design, data was collected through a structured survey from a diverse sample of healthcare professionals. Findings revealed a nuanced landscape of attitudes towards NGDTM, with high awareness and positive attitudes but practical challenges hindering consistent adherence. Healthcare workers expressed uncertainty regarding guideline utilization and adherence, citing time constraints, inadequate training, and organizational culture as significant barriers. Despite these challenges, recommendations emerged to enhance guideline implementation and improve patient outcomes. These included prioritizing continuous training and education programs, addressing medication stockouts, and creating supportive work environments. Moving forward, interventions should focus on fostering positive attitudes towards guidelines, addressing systemic barriers, and promoting collaboration between public and private sectors to standardize practices across healthcare facilities. By addressing these challenges, stakeholders can optimize malaria management practices and ultimately improve health outcomes in Benue State.

References:

[1].   Abossie, A., Yohanes, T., Nedu, A., Tafesse, W., & Damitie, M. (2020). Prevalence of Malaria and Associated Risk Factors Among Febrile Children Under Five Years: A Cross-Sectional Study in Arba Minch Zuria District, South Ethiopia. Infection and Drug Resistance, 13, 363–372. https://doi.org/10.2147/IDR.S223873

[2].   Zekar, L., & Sharman, T. (2023, August 8). Plasmodium Falciparum Malaria. In StatPearls. StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK555962/

[3].   Tsegaye, A. T., Ayele, A., & Birhanu, S. (2021). Prevalence and Associated Factors of Malaria in Children Under the Age of Five Years in Wogera district, Northwest Ethiopia: A Cross-Sectional Study. PloS ONE, 16(10), e0257944. https://doi.org/10.1371/journal.pone.0257944

[4].   World Health Organization [WHO] (2022, December 8). World Malaria Report 2022. Global Report. https://www.who.int/publications/i/item/9789240064898

[5].   World Health Organization [WHO] (2023). Malaria. WHO. https://www.who.int/news-room/fact-sheets/detail/malaria#:~:text=Malaria%20mostly%20spreads%20to%20people,difficulty%20to%20recognize%20as%20malaria.

[6].   Anjorin, S., Okolie, E., & Yaya, S. (2023). Malaria Profile and Socioeconomic Predictors Among Under-Five Children: An Analysis of 11 sub-Saharan African countries. Malaria Journal, 22, 55. https://doi.org/10.1186/s12936-023-04484-8

[7].   Stonely, A. (2023). Prevalence of Malaria in Sub-Saharan Africa. Ballard Brief. Retrieved from https://ballardbrief.byu.edu/issue-briefs/prevalence-of-malaria-in-sub-saharan-africa

[8].   Azevedo M. J. (2017). The State of Health System(s) in Africa: Challenges and Opportunities. Historical Perspectives on the State of Health and Health Systems in Africa, Volume II: The Modern Era, 1–73. https://doi.org/10.1007/978-3-319-32564-4_1

[9].   Badmos, A. O., Alaran, A. J., Adebisi, Y. A., Bouaddi, O., Onibon, Z., Dada, A., Lin, X., & Lucero-Prisno III, D. E. (2012). What Sub-Saharan African Countries can Learn From Malaria Elimination in China. Tropical Medicine and Health, 49, 86. https://doi.org/10.1186/s41182-021-00439-1

[10].  Oladipo, H. J., Tajudeen, Y. A., Oladunjoye, I. O., Yusuff, S. I., Yusuf, R. O., Oluwaseyi, E. M., AbdulBasit, M. O., Adebisi, Y. A., & El-Sherbini, M. S. (2022). Increasing Challenges of Malaria Control in Sub-Saharan Africa: Priorities for Public Health Research and Policymakers. Annals of Medicine And Surgery (2012), 81, 104366. https://doi.org/10.1016/j.amsu.2022.10436

[11].  Andrade, M. V., Noronha, K., Diniz, B. P. C., Guedes, G., Carvalho, L. R., Silva, V. A., Calazans, J. A., Santos, A. S., Silva, D. N., & Castro, M. C. (2022). The Economic Burden of Malaria: A Systematic Review. Malaria Journal, 21, 283. https://doi.org/10.1186/s12936-022-04421-2

[12].  Fernando, S. D., Rodrigo, C., & Rajapakse, S. (2010). The 'hidden' burden of malaria: cognitive impairment following infection. Malaria Journal, 9, 366. https://doi.org/10.1186/1475-2875-9-366

[13].  Gallup, J. L., & Sachs, J. D. (2001). The Economic Burden of Malaria. In J. G. Breman, A. Egan, & G. T. Keusch (Eds.), The Intolerable Burden of Malaria: A New Look at the Numbers: Supplement to Volume 64(1) of the American Journal of Tropical Medicine and Hygiene. Available from: https://www.ncbi.nlm.nih.gov/books/NBK2624/

[14].  Lindsay, S. W., Thomas, M. B., & Kleinschmidt, I. (2021). Threats to The Effectiveness of Insecticide-Treated Bednets for Malaria Control: Thinking Beyond Insecticide Resistance. The Lancet Global Health, Advance Online Publication. https://doi.org/10.1016/S2214-109X(21)00216-3

[15].  Okumu, F. O., & Moore, S. J. (2011). Combining Indoor Residual Spraying and Insecticide-Treated Nets for Malaria Control in Africa: A Review of Possible Outcomes and an Outline of Suggestions for the Future. Malaria Journal, 10, 208. https://doi.org/10.1186/1475-2875-10-208

[16].  Pryce, J., Medley, N., & Choi, L. (2022). Indoor Residual Spraying for Preventing Malaria in Communities Using Insecticide-Treated Nets. The Cochrane Database of Systematic Reviews, 1(1), CD012688. https://doi.org/10.1002/14651858.CD012688.pub3

[17].  Oyerogba, O. P., Adedapo, A., Awokson, T., Odukogbe, A. T., & Aderinto, N. (2023). Prevalence of Malaria Parasitaemia Among Pregnant Women At Booking in Nigeria. Health Science Reports, 6(6), e1337. https://doi.org/10.1002/hsr2.1337

[18].  Nwaneri, D. U., Sadoh, A. E., & Ibadin, M. O. (2020). Assessment of use of National Guidelines for Malaria Case Management among Pediatric Resident Doctors Attending an Update Course in Benin City, Nigeria. Nigerian Medical Journal : Journal of the Nigeria Medical Association, 61(2), 78–83. https://doi.org/10.4103/nmj.NMJ_72_19

[19].  Obasohan, P. E., Walters, S. J., Jacques, R., & Khatab, K. (2021). Individual and Contextual Factors Associated with Malaria among Children 6-59 Months in Nigeria: A Multilevel Mixed Effect Logistic Model Approach. International Journal of Environmental Research and Public Health, 18(21), 11234. https://doi.org/10.3390/ijerph182111234

[20].  Sokunbi, T. O., Omojuyigbe, J. O., Bakenne, H. A., & Adebisi, Y. A. (2022). Nigeria End Malaria Council: What to expect. Annals of Medicine and Surgery (2012), 82, 104690. https://doi.org/10.1016/j.amsu.2022.104690

[21].  World Health Organization. (2015). Guidelines for the Treatment of Malaria. Third edition. Retrieved from https://www.afro.who.int/publications/guidelines-treatment-malaria-third-edition

[22].  Bamiselu, O. F., Ajayi, I., Fawole, O., Dairo, D., Ajumobi, O., Oladimeji, A., & Steven, Y. (2016). Adherence to Malaria Diagnosis and Treatment Guidelines Among Healthcare Workers in Ogun State, Nigeria. BMC Public Health, 16(1), 828. https://doi.org/10.1186/s12889-016-3495-x

[23].  Omale U. I. (2021). Knowledge, Attitude, and Practice of the National Guidelines for Diagnosis and Treatment of Malaria among Medical Doctors in Ebonyi State, Nigeria: A Cross-Sectional Survey. PloS ONE, 16(9), e0257600. https://doi.org/10.1371/journal.pone.0257600

[24].  Obiebi I. P. (2019). Adherence to Antimalarial Drug Policy Among Doctors in Delta State, Nigeria: Implications For Malaria Control. Ghana Medical Journal, 53(2), 109–116. https://doi.org/10.4314/gmj.v53i2.5

[25].  Oyefabi, A., Awaje, M., Usman, N. O., Sunday, J., Kure, S., & Hammad, S. (2023). Knowledge and Compliance with Malaria National Treatment Guidelines among Primary Health Care Workers in a Rural Area in Northern Nigeria. West African Journal of Medicine, 40(5), 469–475.

[26].  Amali, O., Okwori, G., & Awodi, N. O. (2014). Malaria and Anaemia among Pregnant Women in Makurdi, Benue State. Nigerian Journal of Parasitology. Retrieved from https://www.ajol.info/index.php/njpar/article/view/99212#:~:text=The%20prevalence%20of%20malaria%20infection,that%20of%20anaemia%20was%2047.0%25

[27].  Ogbuefi, E., Aribodor, D. N., Joe-Ikechebelu, N. N., Aribodor, O. B., Okechukwu, I. C., Orjichukwu, O. N., & Vivian Obiamaka, E.-O. (2023). Epidemiological Studies of Malaria in Gboko Metropolis, Gboko Local Government Area of Benue State, Nigeria. Tropical Journal of Medical Research, 22(1), 49–58. Retrieved from https://tjmr.org.ng/index.php/tjmr/article/view/93

[28].  Aju-Ameh, C., Awolola, S., Mwansat, G., & Mafuyai, H. (2017). Prevalence of Asymptomatic Malaria in Selected Communities in Benue state, North Central Nigeria: A Silent Threat to the National Elimination Goal. Edorium J Epidemiol, 3, 1–7.

[29].  Amagu, N., Obisike, V. U., & Amuta, E. U. (2019). The KAPP Study of Malaria and its Prevalence amongst Boarding School Students in Gboko Local Government Area of Benue State, Nigeria. International Blood Research & Reviews, 10(2), 1–7. https://doi.org/10.9734/ibrr/2019/v10i230115

[30].  USAID (2023). President’s Malaria Initiative for States (PMI-S) Task Order 4 Quarterly Report Third Quarter FY2022 – April 1 to June 30, 2022. https://pdf.usaid.gov/pdf_docs/PA00ZMFT.pdf

[31].  Faga, D. C., Obisike, V. U., Onah, I. E., & Amuta, E. U. (2020). Assessment of Malaria Parasitemia and Genotype of Patients Attending Two Hospitals in Benue State, Nigeria. African Research Review, 14(1). Retrieved from https://www.ajol.info/index.php/ari/article/view/199322

[32].  Hochbaum, G. M. (1958). Public Participation in Medical Screening Programs: A Socio-Psychological Study. U.S. Department of Health, Education, and Welfare, Public Health Service, Bureau of State Services, Division of Special Health Services, Tuberculosis Program. Rosenstock, I. M. (1960). What research in Motivation Suggests for Public Health. American Journal of Public Health and the Nations Health, 50(3), 295–302. https://doi.org/10.2105/AJPH.50.3_Part_2.295

[33].  Rosenstock I. M. (1960). What Research in Motivation Suggests for Public Health. American Journal of Public Health and the Nation's Health, 50(3 Pt 1), 295–302. https://doi.org/10.2105/ajph.50.3_pt_1.295

[34].  Janz, N. K., & Becker, M. H. (1984). The Health Belief Model: A Decade Later. Health Education Quarterly, 11(1), 1–47. https://doi.org/10.1177/109019818401100101

[35].  Bandura, A. (1977). Self-efficacy: Toward a Unifying Theory of Behavioral Change. Psychological Review, 84(2), 191–215. https://doi.org/10.1037/0033-295X.84.2.191

[36].  Rosenstock, I. M., Strecher, V. J., & Becker, M. H. (1988). Social Learning Theory and the Health Belief Model. Health Education Quarterly, 15(2), 175–183. https://doi.org/10.1177/109019818801500203

[37].  Champion, V. L., & Skinner, C. S. (2008). The Health Belief Model. In K. Glanz, B. K. Rimer, & K. Viswanath (Eds.), Health Behavior and Health Education: Theory, Research, And Practice (4th ed., pp. 45–65). Jossey-Bass.

[38].  Ajzen, I. (1991). The Theory of Planned Behavior. Organizational Behavior and Human Decision Processes, 50(2), 179–211.

[39].  Fishbein, M., & Ajzen, I. (2010). Predicting and Changing Behavior: The Reasoned Action Approach. Psychology Press.

[40].  Armitage, C. J., & Conner, M. (2001). Efficacy of the Theory of Planned Behaviour: A Meta-analytic Review. British Journal of Social Psychology, 40(4), 471–499.

[41].  Jogulu, U. D., & Pansiri, J. (2011). Mixed Methods: A Research Design for Management Doctoral Dissertations. Management Decision, 49(8), 1226–1238.

[42].  Park, Y., Konge, L., & Artino, A. R. (2020). The Positivism Paradigm of Research. Academic Medicine: Journal of the Association of American Medical Colleges, 95(5). http://dx.doi.org/10.1097/ACM.0000000000003093

[43].  Cochran, W. G. (1963). Sampling Techniques (2^nd ed.). John Wiley & Sons.

[44].  Thompson, S. K., & Seber, G. A. F. (1996). Adaptive Sampling. John Wiley & Sons.

[45].  Babbie, E. R. (2016). The Practice of Social Research. USA: Cengage Learning.

[46].  Krejcie, R. V., & Morgan, D. W. (1970). Determining Sample Size for Research Activities. Educational and Psychological Measurement, 30(3), 607–610. https://doi.org/10.1177/001316447003000308

[47].  Tavakol, M., & Dennick, R. (2011). Making sense of Cronbach's alpha. International Journal of Medical Education, 2, 53–55. https://doi.org/10.5116/ijme.4dfb.8dfd

[48].  Blanco, M., Suárez-Sanchez, P., García, B., Nzang, J., Ncogo, P., Riloha, M., Berzosa, P., Benito, A., & Romay-Barja, M. (2021). Knowledge and Practices Regarding Malaria and the National Treatment Guidelines Among Public Health Workers In Equatorial Guinea. Malaria Journal, 20(1), 21. https://doi.org/10.1186/s12936-020-03528-7

[49].  Zalwango, J. F., Nankabirwa, J. I., Kitutu, F. E., Akunzirwe, R., Buhuguru, R., Rokani, J. B., Kalyango, J. N. (2022). Malaria Diagnostic and Treatment Practices for Febrile Children Under 5 Years at Two General Hospitals in Karamoja, A High Transmission Setting in Uganda. Malaria Journal, 21, 312. https://doi.org/10.1186/s12936-022-04329-w

[50].  Gindola, Y., Getahun, D., Sugerman, D., Tongren, E., Tokarz, R., Wossen, M., Demissie, K., Zemelak, E., Okugn, A., Wendimu, J., Hailu, G., Tegistu, M., & Begna, D. (2022). Adherence to National Malaria Clinical Management and Testing Guidelines In Selected Private Clinics of Gambela Town, Gambela Region, Ethiopia: a Mixed Method Study. Malaria Journal, 21(1), 164. https://doi.org/10.1186/s12936-022-04206-6

[51].  Riley, C., Dellicour, S., Ouma, P., Kioko, U., ter Kuile, F. O., Omar, A., Kariuki, S., Buff, A. M., Desai, M., & Gutman, J. (2016). Knowledge and Adherence to the National Guidelines for Malaria Case Management in Pregnancy among Healthcare Providers and Drug Outlet Dispensers in Rural, Western Kenya. PloS ONE, 11(1), e0145616. https://doi.org/10.1371/journal.pone.0145616

[52].  Argaw, M. D., Mavundla, T. R., Gidebo, K. D., Desta, B. F., Damte, H. D., Mebratu, W., Edossa, W., Dillu, D., Mitiku, A. D., & Desale, A. Y. (2022). Adherence of Healthcare Providers to Malaria Case Management Guidelines of the Formal Private Sector in North-Western Ethiopia: An Implication for Malaria Control and Elimination. Malaria Journal, 21(1), 347. https://doi.org/10.1186/s12936-022-04379-0

Abstract:

The demand for oxygen during the COVID-19 has no equivalent in the past and caused a lot of strain on the hospital infrastructure as well as raised concerns about the ability of oxygen systems to meet the escalating needs of patients. This is a literature review on the demand for oxygen therapy during the COVID-19 pandemic. The purpose of this study is to conduct an in-depth evaluation of previous studies on the demand for oxygen therapy during the COVID-19 pandemic. The study assesses the current understanding of the topic because of its relevance and influence on the health of different populations around the world. Pub Med, Science Direct, Google Scholar, the Lancet and EBSCO were searched using a series of combinations of the following keywords: oxygen demand during the COVID-19 pandemic, oxygen therapy, COVID-19 pandemic, access to oxygen therapy during the COVID-19 pandemic, challenges of oxygen services delivery and medical oxygen. The findings revealed that the COVID-19 pandemic led to a substantial increase in the demand for oxygen therapy around the world due to the respiratory complications associated with the disease. The average monthly utilization of oxygen has increased due to the persistent increase in demand. Many health systems struggled to deliver oxygen therapy however, their efforts were futile due to the sudden increase in the number of patients that require oxygen therapy; problems related to the medical oxygen supply chain; lack of capacity to deliver oxygen therapy due to limits in infrastructure as well as other challenges.

References:

[1].   Brakefield, W. S., Ammar, N., Olusanya, O. A. & Shaban-Nejad, A. (2021) “An Urban Population Health Observatory System to Support COVID-19 Pandemic Preparedness, Response, and Management: Design and Development Study,” JMIR Public Health Surveill 7(6):e28269), Available from: https://publichealth.jmir.org/2021/6/e28269, Doi: 10.2196/28269 (Accessed: 20/06/2021).

[2].   World Health Organization. Clinical Management of Severe Acute Respiratory Infection (SARI) when COVID‑19 Disease is Suspected. Interim Guidance, 2020, Available from: https://www.who.int/docs/default‑source/coronaviruse/clinical‑management‑of‑novel‑cov.pdf?sfvrsn=bc7da517_2

[3].   Hidalgo, J., Rodrı´guez-Vega, G. and Perez-Ferna´ndez, J. (2021) “The Sudden Appearance of SARS-CoV-2,” in, COVID-19 Pandemic [Online]. Elsevier. Available from: https://doi.org/10.1016/B978-0-323-82860-4.00004-5 (Accessed 21/06/2021).

[4].   Bashier, H., Ikram, A., Ali Khan, M., Baig, M., Al Gunaid, M., Al Nsour, M. & Khader, Y. (2021) “The Anticipated Future of Public Health Services Post COVID-19: Viewpoint,” JMIR Public Health Surveill, 7(6):e26267), Available from: https://publichealth.jmir.org/2021/6/e26267, DOI:10.2196/26267 (Accessed: 20/06/2021)

[5].   Lidoriki, I., Frountzas, M., Schizas, D., (2020) “Could Nutritional and Functional Status Serve as Prognostic Factors for COVID-19 in the Elderly?” Med Hypotheses,1 44:109946. Available from: www.sciencedirect.com (Accessed 26/08/2020).

[6].   World Health Organization (2021) “WHO Coronavirus (COVID-19) Dashboard,” Available from: https://covid19.who.int (Accessed 21/06/2023).

[7].   Center for Disease Control and Prevention (2021) “COVID Data Tracker,” Available from: https://covid.cdc.gov/covid-datatracker-home (Accessed: 21/06/2023)

[8].   Nicola, M., Alsafi, Z., Sohrabi, C., Kerwan, A., Al-Jabir, A. & Iosifidis, C. (2020), “The Socio-Economic Implications of the Corona virus and COVID-19 Pandemic: A Review. International Journal of Surgery.

[9].   Aldridge, R. W., Lewer, D., Katikireddi, S. V., Mathur, R., Pathak, N., Burns, R., (2020) “Black, Asian and Minority Ethnic Groups in England are at Increased Risk of Death from COVID-19: Indirect Standardization of NHS Mortality Data.” Wellcome Open Res. 5 (88) p. 88. Available from:

[10].  Grant, W. B., Lahore, H., McDonnell, S. L., Baggerly, C. A., French, C. B., Aliano, J. L., (2020), “Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths” Nutrients, 12 (4) p. 988.

[11].  D'Adamo, H., Yoshikawa, T. & Ouslander, J. G. (2020) “Corona virus Disease 2019 in Geriatrics and Long‐Term Care: The ABCDs of COVID‐19.” Journal of American Geriatric Soc. 68 (5) pp 912-7.

[12].  Ismail, J. & Bansal, A. (2022) “Medical Oxygen: A Lifesaving Drug during the COVID‑19 Pandemic—Source and Distribution,” Indian Journal of Pediatrics, 89(6):607–615, https://doi.org/10.1007/s12098-021-03978-0

[13].  White, H. D., Danesh, V., Jimenez, E. J. & Arroliga, A. C., (2023) “Oxygen Supply and Demand during the COVID-19 Pandemic: An Integrated Health System Perspective,” Am J Respir Crit Care Med, 207:A2874: www.atsjournals.org (Online Abstracts Issue).

[14].  Suh, H. J., Lee, E. and Park, S-W. (2021) “Clinical Characteristics of COVID-19: Risk Factors for Early Oxygen Requirement after Hospitalization,” J Korean Med Sci., 2021, Available from: https://doi.org/10.3346/jkms.2021.36.e139

[15].  Radhakrishnan, R. V., Mohanty, C. R., Singh, N. (2021) “The Balancing Act of Hospital Medical Oxygen Demand and Supply: The Need of the Hour in COVID‑19 Pandemic,” Saudi J Anaesth ; 15; 465-7.

[16].  Reese, H., Iuliano, D., Patel, N. N., Garg, S., Kim, L., Silk, B. J., Hall, A. J., Fry, A. and Reed, C. (2021) “Estimated Incidence of Coronavirus Disease 2019 (COVID-19) Illness and Hospitalization—United States, February–September 2020,” Clinical Infectious Diseases, Available from: https://doi.org/10.1093/cid/ciaa1780

[17].  Birkmeyer, J. D., Barnato, A., Birkmeyer, N., Bessler, R. and Skinner, J. (2020) “The Impact of the COVID-19 Pandemic on Hospital Admissions in the United States,” Health Affairs 39, https://doi.org/10.1377/hlthaff.2020.00980

[18].  Shikha et al. (2020) “Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020,” MMWR, 69 (15): US Department of Health and Human Services/Centers for Disease Control and Prevention.

[19].  Soares, R. C. M., Mattos, L. R. and Raposo, L. M. (2020) “Risk Factors for Hospitalization and Mortality due to COVID-19 in Esp´ırito Santo State, Brazil,” Am. J. Trop. Med. Hyg., 103(3), 2020, pp. 1184–1190, https://doi.org/10.4269/ajtmh.20-0483

[20].  Saadatmand et al. (2022) “Predicting the Necessity of Oxygen Therapy in the Early Stage of COVID‑19 Using Machine Learning,” Medical & Biological Engineering & Computing, 60:957–968: https://doi.org/10.1007/s11517-022-02519-x

[21].  Kapoor, G., Hauck, S., Sriram, A., Joshi, J., Schueller, E., Frost, I., et al. (2020) “State‑wise Estimates of Current Hospital Beds, Intensive Care Unit (ICU) Beds And Ventilators in India: Are we Prepared for a Surge in COVID‑19 Hospitalizations?” MedRxiv, Available from: https://doi.org/10.1101/2020.06.16.20132787

[22].  Lee, E. E et al (2021) “Predication of Oxygen Requirement in COVID-19 Patients Using Dynamic Change of Inflammatory Markers: CRP, Hypertension, Age, Neutrophil and Lymphocyte (CHANeL).” Sci Rep. 11(1):13026. https://doi.org/10.1038/s41598-021-92418-2

Abstract:

The risk of depression among Malaysian adolescents has been on the rise in recent years. Families, as the key to preventing depression in adolescents, should pay attention to the mental health of adolescents, improve family functioning, and strengthen emotional and other aspects of support. This research explored the relationship between family emotional support and adolescent depression, focusing on strategies to enhance family emotional support, and the impact of family emotional support. This is a qualitative study where depressed adolescents from the Tzu Chi Life Care Group in Penang were selected and semi-structured interviews were conducted with twelve respondents finally the interviews were coded and summarized using thematic analysis. According to research findings, enhancing family emotional support can help increase the resilience of depressed adolescents and families, thereby alleviating adolescent depression and improving mental health. The intervention of social workers through professional methods has helped families respond to the emotional needs of depressed adolescents, respect their personalities, optimize parenting styles, and increase family interactions, which has helped to increase family emotional support for depressed adolescents. Social workers served as a bridge to intervene in family services for depressed adolescents. In the future field of adolescent mental health services in Malaysia, the emphasis on the introduction of social workers and family support may be more conducive to the alleviation of adolescent depression.

References:

[1] World Health Organization, Depressive disorder (depression). Date of access: 21/03/2023. https://www.who.int/news-room/fact-sheets/detail/depression

[2] Shorey, S., Ng, E. D., & Wong, C. H. J., 2022, Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta-analysis. British Journal of Clinical Psychology, 61(2), 287–305.

[3] Richards, D., 2011, Prevalence and clinical course of depression: A review. Clinical Psychology Review, 31(7), 1117–1125.

[4] U.S. Department of Health and Human Services. Major depression. National Institute of Mental Health. Date of access: 02/07/2023. https://www.nimh.nih.gov/health/statistics/major-depression

[5] Maughan, B., Collishaw, S., & Stringaris, A., 2013, Depression in Childhood and Adolescence. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 22(1), 35–40.

[6] Guassi Moreira, J. F., & Telzer, E. H., 2015, Changes in family cohesion and links to depression during the College Transition. Journal of Adolescence, 43(1), 72–82.

[7] John Wong, Lin Jo Yan and Yeo Boon Khim, 2023, Building Resilience is Key to Good Mental Health: NUS Youth Epidemiology and Resilience Study. Press Release, The NUS Yong Loo Lin School of Medicine.

[8] Kroning M., & Kroning K., 2016, Teen Depression and Suicide: A Silent Crisis. Journal of Christian Nursing, 33(2), 78.

[9] Blackdoginstitute. Critical study into Youth Depression enters its fourth year - Black Dog Institute: Better Mental Health. Date of access: 02/02/2023. https://www.blackdoginstitute.org.au/media-releases/critical-study-into-youth-depression-enters-its-fourth-year/

[10] NHMS, NHMS 2017. Date of access: 05/10/2023. https://iku.moh.gov.my/nhms-2017

[11] Institute for Public Health, National Institutes of Health and Ministry of Health Malaysia, 2022, National Health and Morbidity Survey 2022: Adolescent Health Survey

[12] Singh, S., Lai, C. H., Iderus, N. H. M., Ghazali, S. M., Ahmad, L. C. R. Q., Cheng, L. M., Nadzri, M. N., Zulkifli, A. A., Suppiah, J., Zaki, R. A., Farid, N. D. N., Supramanian, R. K., Nordin, A. A., Lin, C. Z., Kaur, K., & Ghazali, N. M., 2023, Prevalence and Determinants of Depressive Symptoms among Young Adolescents in Malaysia: A Cross-Sectional Study. Children, 10(1), Article 1.

[13] Abdul Aziz, F. A., Abd Razak, M. A., Ahmad, N. A., Awaluddin, S. M., Lodz, N. A., Sooryanarayana, R., Shahein, N. A., Mohamad Kasim, N., Abd Wahab, N., & Jamaluddin, R., 2019, Factors Associated With Suicidal Attempt Among School-Going Adolescents in Malaysia. Asia Pacific Journal of Public Health, 31(8_suppl), 73S-79S.

[14] Latiff, L., Tajik, E., Ibrahim, N., Abubakar, A. S., & Ali, S. S., 2016, Depression and Its Associated Factors among Secondary School Students in Malaysia. 47, 131–141.

[15] Ang, J. K., Phang, C. K., Mukhtar, F., Osman, Z. J., Awang, H., Sidik, S. M., Ibrahim, N., & Ghaffar, S. F. A., 2018, Association between perceived parental style and depressive symptoms among adolescents in Hulu Langat District, Malaysia. International Journal of Adolescent Medicine and Health, 30(6), 20160130.

[16] Barra, S. M., Baharudin, R., Zulkefly, N. S., Yahya, A., & Madon, Z., 2019, Stressful Life Events, Parental Verbal Aggression and Depressive Symptoms in Malaysian Adolescents: The Moderating Role of Parental Warmth. Pertanika Journal of Social Science and Humanities, 27, 1903–1925.

[17] Liyin, W., Kamarul Bahrin, F., Mohamad Yusof, M., & Yahaya, M., 2023, Exploring the mentalhealth of minors in poor areas: A case study of anhui province, China. Texila International Journal of Public Health, 11(4), 325–338.

[18] White, L., 1999, Contagion in Family Affection: Mothers, Fathers, and Young Adult Children. Journal of Marriage and the Family, 61(2), 284.

[19] Young, K. S., Sandman, C. F., & Craske, M. G., 2019, Positive and Negative Emotion Regulation in Adolescence: Links to Anxiety and Depression. Brain Sciences, 9(4), Article 4.

[20] Wang, Y., Tian, L., Guo, L., & Huebner, E. S., 2020, Family dysfunction and Adolescents’ anxiety and depression: A multiple mediation model. Journal of Applied Developmental Psychology, 66, 101090.

[21] Morris, A. S., Silk, J. S., Steinberg, L., Myers, S. S., & Robinson, L. R., 2007, The role of the family context in the development of Emotion Regulation. Social Development, 16(2), 361–388.

[22] Bodner, N., Kuppens, P., Allen, N. B., Sheeber, L. B., & Ceulemans, E., 2018, Affective family interactions and their associations with adolescent depression: A dynamic network approach. Development and Psychopathology, 30(4), 1459–1473.

[23] Hesse, C., Rauscher, E. A., Roberts, J. B., & Ortega, S. R., 2014, Investigating the Role of Hurtful Family Environment in the Relationship Between Affectionate Communication and Family Satisfaction. Journal of Family Communication, 14(2), 112–128.

[24] Skrove, M., Romundstad, P., & Indredavik, M. S., 2013, Resilience, lifestyle and symptoms of anxiety and depression in adolescence: The Young-HUNT study. Social Psychiatry and Psychiatric Epidemiology, 48(3), 407–416.

[25] Cummings, E. M., Koss, K. J., & Davies, P. T., 2015, Prospective Relations between Family Conflict and Adolescent Maladjustment: Security in the Family System as a Mediating Process. Journal of Abnormal Child Psychology, 43(3), 503–515.

[26] Cassels, M., van Harmelen, A.-L., Neufeld, S., Goodyer, I., Jones, P. B., & Wilkinson, P., 2018, Poor family functioning mediates the link between childhood adversity and adolescent nonsuicidal self-injury. Journal of Child Psychology and Psychiatry, 59(8), 881–887.

[27] Stolz, H. E., Barber, B. K., & Olsen, J. A., 2005, Toward disentangling fathering and mothering: An assessment of relative importance. Journal of Marriage and Family, 67(4), 1076–1092.

[28] Schrodt, P., Ledbetter, A. M., & Ohrt, J. K., 2007, Parental confirmation and affection as mediators of family communication patterns and children’s mental well-being. Journal of Family Communication, 7(1), 23–46.

[29] Cooper, K., Hards, E., Moltrecht, B., Reynolds, S., Shum, A., McElroy, E., & Loades, M., 2021, Loneliness, social relationships, and mental health in adolescents during the COVID-19 pandemic. Journal of Affective Disorders, 289, 98–104.

[30] Yockey, R. A., King, K. A., & Vidourek, R. A., 2021, Family factors and parental correlates to adolescent conduct disorder. Journal of Family Studies, 27(3), 356–365.

[31] Smith, O. A., Nelson, J. A., & Adelson, M. J., 2019, Interparental and Parent–Child Conflict Predicting Adolescent Depressive Symptoms. Journal of Child and Family Studies, 28(7), 1965–1976.

[32] Moltrecht, B., Deighton, J., Patalay, P., & Edbrooke-Childs, J., 2021, Effectiveness of current psychological interventions to improve emotion regulation in youth: A meta-analysis. European Child & Adolescent Psychiatry, 30(6), 829–848.

[33] Daros, A. R., Haefner, S. A., Asadi, S., Kazi, S., Rodak, T., & Quilty, L. C., 2021, A meta-analysis of emotional regulation outcomes in psychological interventions for youth with depression and anxiety. Nature Human Behaviour, 5(10), Article 10.

[34] Chi, X., Bo, A., Liu, T., Zhang, P., & Chi, I., 2018, Effects of mindfulness-based stress reduction on depression in adolescents and young adults: A systematic review and meta-analysis. Frontiers in Psychology, 9.

[35] Dunning, D. L., Griffiths, K., Kuyken, W., Crane, C., Foulkes, L., Parker, J., & Dalgleish, T. ,2019, Research Review: The effects of mindfulness-based interventions on cognition and mental health in children and adolescents – a meta-analysis of randomized controlled trials. Journal of Child Psychology and Psychiatry, 60(3), 244–258.

[36] Lindqvist, K., Mechler, J., Carlbring, P., Lilliengren, P., Falkenström, F., Andersson, G., Johansson, R., Edbrooke-Childs, J., Dahl, H.-S. J., Bergsten, K. L., Midgley, N., Sandell, R., Thorén, A., Topooco, N., Ulberg, R., & Philips, B., 2020, Affect-Focused Psychodynamic Internet-Based Therapy for Adolescent Depression: Randomized Controlled Trial. Journal of Medical Internet Research, 22(3), e18047.

[37] Spruit, A., Goos, L., Weenink, N., Rodenburg, R., Niemeyer, H., Stams, G. J., & Colonnesi, C.,2020, The Relation Between Attachment and Depression in Children and Adolescents: A Multilevel Meta-Analysis. Clinical Child and Family Psychology Review, 23(1), 54–69.

[38] Chen, P., & Harris, K. M., 2019, Association of Positive Family Relationships With Mental Health Trajectories From Adolescence to Midlife. JAMA Pediatrics, 173(12), e193336.

[39] Diamond, G. S., Kobak, R. R., Krauthamer Ewing, E. S., Levy, S. A., Herres, J. L., Russon, J. M., & Gallop, R. J., 2019, A Randomized Controlled Trial: Attachment-Based Family and Nondirective Supportive Treatments for Youth Who Are Suicidal. Journal of the American Academy of Child & Adolescent Psychiatry, 58(7), 721–731.

[40] Khademi, M., Hajiahmadi, M., & Faramarzi, M., 2019, The role of long-term psychodynamic psychotherapy in improving attachment patterns, defense styles, and alexithymia in patients with depressive/anxiety disorders. Trends in Psychiatry and Psychotherapy, 41, 43–50.

[41] McGuire, A., Gillath, O., Jackson, Y., & Ingram, R., 2018, Attachment security priming as a potential intervention for depressive symptoms. Journal of Social and Clinical Psychology, 37(1), 44–68.

[42] Koehn, A. J., & Kerns, K. A., 2018, Parent–child attachment: Meta-analysis of associations with parenting behaviors in middle childhood and adolescence. Attachment & Human Development, 20(4), 378–405.

[43] Dardas, L. A., Van De Water, B., & Simmons, L. A., 2018, Parental involvement in adolescent depression interventions: A systematic review of randomized clinical trials. International Journal of Mental Health Nursing, 27(2), 555–570.

[44] Zhao, F., Liu, M., & Li, S., 2020, Paternal coparenting behavior and adolescent prosocial behaviors: Roles of parent-child attachment, peer attachment, and gender. Children and Youth Services Review, 119, 105629.

[45] Carr, A., 2019, Family therapy and systemic interventions for child‐focused problems: The current evidence base. Journal of Family Therapy, 41(2), 153–213.

[46] Kumpfer, K. L., & Magalhães, C., 2018, Strengthening families program: An evidence-based family intervention for parents of high-risk children and adolescents. Journal of Child & Adolescent Substance Abuse, 27(3), 174–179.

[47] Cardamone-Breen, M. C., Jorm, A. F., Lawrence, K. A., Rapee, R. M., Mackinnon, A. J., & Yap, M. B. H., 2018, A Single-Session, Web-Based Parenting Intervention to Prevent Adolescent Depression and Anxiety Disorders: Randomized Controlled Trial. Journal of Medical Internet Research, 20(4), e9499.

[48] Brown, F. L., Steen, F., Taha, K., Aoun, M., Bryant, R. A., Jordans, M. J. D., Malik, A., van Ommeren, M., Abualhaija, A., Aqel, I. S., Ghatasheh, M., Habashneh, R., Sijbrandij, M., El Chammay, R., Watts, S., Akhtar, A., & on behalf of the STRENGTHS-consortium., 2019, Early Adolescent Skills for Emotions (EASE) intervention for the treatment of psychological distress in adolescents: Study protocol for randomised controlled trials in Lebanon and Jordan. Trials, 20(1), 545.

[49] Bevan Jones, R., Thapar, A., Stone, Z., Thapar, A., Jones, I., Smith, D., & Simpson, S., 2018, Psychoeducational interventions in adolescent depression: A systematic review. Patient Education and Counseling, 101(5), 804–816.

[50] Aguirre Velasco, A., Cruz, I. S. S., Billings, J., Jimenez, M., & Rowe, S., 2020, What are the barriers, facilitators and interventions targeting help-seeking behaviours for common mental health problems in adolescents? A systematic review. BMC Psychiatry, 20(1), 293.

[51] Poole, L. A., Knight, T., Toumbourou, J. W., Lubman, D. I., Bertino, M. D., & Lewis, A. J.,2018, A Randomized Controlled Trial of the Impact of a Family-Based Adolescent Depression Intervention on both Youth and Parent Mental Health Outcomes. Journal of Abnormal Child Psychology, 46(1), 169–181.

[52] Malti, T., Beelmann, A., Noam, G. G., & Sommer, S., 2018, Innovation and Integrity in Intervention Research: Conceptual Issues, Methodology, and Knowledge Translation. Prevention science: the official journal of the Society for Prevention Research, 19(3), 271–273.

[53] Eckshtain, D., Kuppens, S., Ugueto, A., Ng, M. Y., Vaughn-Coaxum, R., Corteselli, K., & Weisz, J. R., 2020, Meta-Analysis: 13-Year Follow-up of Psychotherapy Effects on Youth Depression. Journal of the American Academy of Child & Adolescent Psychiatry, 59(1), 45–63.

[54] Kamarul Bahrin, F., A/L Klai, M., & Mohamad Yusof, M., 2023, The awareness of depression among school teachers at SMKA Al-Mashoor Perempuan, Penang Island. Texila International Journal of Public Health, 11(4), 256–268.

[55] De Saxe Zerden, L., Lombardi, B. M., Fraser, M. W., Jones, A., & Rico, Y. G., 2018, Social work: Integral to interprofessional education and integrated practice. Journal of Interprofessional Education & Practice, 10, 67–75.

[56] Craig, S., Frankford, R., Allan, K., Williams, C., Schwartz, C., Yaworski, A., Janz, G., & Malek-Saniee, S., 2016, Self-reported patient psychosocial needs in Integrated Primary Health Care: A role for social work in interdisciplinary teams. Social Work in Health Care, 55(1), 41–60.

[57] Colizzi, M., Lasalvia, A., & Ruggeri, M., 2020, Prevention and early intervention in youth mental health: Is it time for a multidisciplinary and trans-diagnostic model for care? International Journal of Mental Health Systems, 14(1).

[58] Kiger, M. E., & Varpio, L., 2020, Thematic analysis of qualitative data: AMEE Guide No. 131. Medical teacher, 42(8), 846–854.

[59] García-Carrión, R., Villarejo-Carballido, B., & Villardón-Gallego, L., 2019, Children and adolescents mental health: A systematic review of interaction-based interventions in schools and communities. Frontiers in Psychology, 10.

[60] Ingram, K. M., Espelage, D. L., Davis, J. P., & Merrin, G. J., 2020, Family Violence, Sibling, and Peer Aggression During Adolescence: Associations With Behavioral Health Outcomes. Frontiers in Psychiatry, 11.

[61] Trong Dam, V. A., Do, H. N., Thi Vu, T. B., Vu, K. L., Do, H. M., Thi Nguyen, N. T., Nguyen, T. T., Thi Vu, T. M., Thi Nguyen, T. P., Auquier, P., Boyer, L., Fond, G., Latkin, C. A., Ho, C. S. H., & Ho, R. C. M., 2023, Associations between parent-child relationship, self-esteem, and resilience with life satisfaction and mental wellbeing of adolescents. Frontiers in Public Health, 11, 1012337.

[62] Lippold, M. A., Davis, K. D., Lawson, K. M., & McHale, S. M., 2016, Day-to-day Consistency in Positive Parent–Child Interactions and Youth Well-Being. Journal of Child and Family Studies, 25(12), 3584–3592.

[63] Weinstein, N., Huo, A., & Itzchakov, G., 2021, Parental listening when adolescents self-disclose: A preregistered experimental study. Journal of Experimental Child Psychology, 209, 105178.

[64] Crandall, A., Powell, E. A., Bradford, G. C., Magnusson, B. M., Hanson, C. L., Barnes, M. D., Novilla, M. L. B., & Bean, R. A., 2020, Maslow’s Hierarchy of Needs as a Framework for Understanding Adolescent Depressive Symptoms Over Time. Journal of Child and Family Studies, 29(2), 273–281.

[65] Gorostiaga, A., Aliri, J., Balluerka, N., & Lameirinhas, J., 2019, Parenting Styles and Internalizing Symptoms in Adolescence: A Systematic Literature Review. International Journal of Environmental Research and Public Health, 16(17), Article 17.

[66] Costa, S., Sireno, S., Larcan, R., & Cuzzocrea, F., 2019, The six dimensions of parenting and adolescent psychological adjustment: The mediating role of psychological needs. Scandinavian Journal of Psychology, 60(2), 128–137.

[67] Fritz, J., de Graaff, A. M., & Caisley, H., 2018, A Systematic Review of Amenable Resilience Factors That Moderate and/or Mediate the Relationship Between Childhood Adversity and Mental Health in Young People. Frontiers in Psychiatry, 9.

[68] Gallagher, M. L., & Miller, A. B., 2018, Suicidal Thoughts and Behavior in Children and Adolescents: An Ecological Model of Resilience. Adolescent Research Review, 3(2), 123–154.

[69] Fosco, G. M., & Lydon-Staley, D. M., 2020, Implications of Family Cohesion and Conflict for Adolescent Mood and Well-Being: Examining Within- and Between-Family Processes on a Daily Timescale. Family Process, 59(4), 1672–1689.

[70] Southam-Gerow, M. A., McLeod, B. D., Brown, R. C., Quinoy, A. M., & Avny, S. B., 2011, Cognitive-Behavioral Therapy for Adolescents. In Encyclopedia of Adolescence (pp. 100–108). Elsevier.

[71] Garnefski, N., & Kraaij, V., 2018, Specificity of relations between adolescents’ cognitive emotion regulation strategies and symptoms of depression and anxiety. Cognition and Emotion, 32(7), 1401–1408.

[72] Dietz, L. J., 2020, Family-Based Interpersonal Psychotherapy: An Intervention for Preadolescent Depression. American Journal of Psychotherapy, 73(1), 22–28.

[73] Kuo, C., LoVette, A., Stein, D. J., Cluver, L. D., Brown, L. K., Atujuna, M., Gladstone, T. R. G., Martin, J., & Beardslee, W., 2019, Building resilient families: Developing family interventions for preventing adolescent depression and HIV in low resource settings. Transcultural Psychiatry, 56(1), 187–212.

Abstract:

COVID-19 vaccines play a crucial role in reducing illness and death caused by SARS-CoV-2 infection. Despite their availability, disparities in vaccine uptake persist among low-income earners in Nigeria. Community organizations are vital in spreading essential vaccine information, understanding reasons for vaccine hesitancy, and promoting vaccine acceptance among the communities they serve. This study aimed to assess perceptions of COVID-19 vaccines among low-income communities in Oshodi/Isolo Local Government Area, Lagos State, Nigeria. Using a descriptive cross-sectional study design, data were collected from consenting adults via structured questionnaires with closed-ended questions. A total of 651 respondents participated, with the majority from Ejigbo (36.1%), followed by Isolo (33.9%), and Oshodi (30.0%). Most respondents were aged 18-45 years, and nearly equal numbers of males and females participated. Respondents' perceptions of COVID-19 vaccines were assessed through eight questions. Overall, perceptions were positive, with Ejigbo showing slightly higher perception scores compared to Isolo and Oshodi. Trust in the scientists who developed these vaccines likely contributed to this positive perception. While citizens were willing to receive COVID-19 vaccines, distrust in government programs and religious beliefs could hinder vaccination efforts. Targeted educational initiatives are necessary to address misconceptions, particularly in communities where religious beliefs strongly influence health decisions. Rebuilding trust between the government and citizens is crucial for achieving higher vaccination rates against COVID-19.

References:

[1] Pal M., Berhanu G., Desalegn C., Kandi V., 2020, Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV 2): an update. Cureus. https://doi.org/10.7759/cureus.7423.

[2] Cucinotta D., Vanelli M., 2020, WHO declares COVID-19 a pandemic. Acta biomedical Atenei Parm, 91: 157–60.

[3] World Health Organization, 2021, WHO Coronavirus Disease (COVID-19) Dashboard, https://covid19.who.int/?gclid=EAIaIQobChMI2p622Oe6wIVxJrVCh0DJgDvEAAYASAAEgIeFfD_BwE.

[4] World Health Organization (WHO), 2022,WHO Coronavirus (COVID-19) Dashboard.

[5] NCDC. COVID-19 NIGERIA. Accessed 7th January 2022.

[6] World Population Review. Nigeria Population 2022 (Live). Accessed 7th January 2022

[7] NPHCDA. Welcome Message from the ED/CEO. Accessed 7th January 2022.

[8] Our World in Data, 2022, Coronavirus Pandemic (COVID-19). Accessed 7th January 2022.

[9] Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD et al., 2022, Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines (Basel), 8(3), 482.

[10] World Health Organization (WHO)., 2020 Behavioural considerations for acceptance and uptake of COVID-19 vaccines: WHO technical advisory group on behavioural insights and sciences for health, meeting report, 15 October. Accessed 7th January 2022.

[11] MacDonald N. E., 2015, Vaccine hesitancy: Definition, scope and determinants. Vaccine. 33(34), 4161-4164.

[12] Larson H. J., Jarrett C., Eckersberger E., Smith D. M. D., 2014, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007-2012. Vaccine. 32(19),a 2150-2159.

[13] Wang J., Jing R., Lai X., Zhang H., Lyu Y., Knoll M. D. et al., 2020, Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines (Basel). 8(3), 482.

[14] Ferdous M. Z., Islam M. S., Sikder M. T., Mosaddek A. S. M., Zegarra-Valdivia J. A., Gozal D., 2020, Knowledge, attitude, and practice regarding COVID-19 outbreak in Bangladesh: an online-based cross-sectional study. PLoS One. 15(10), e0239254. https://doi.org/10.1371/journal.pone.0239254.

[15] Graffigna G., Palamenghi L., Boccia S., Barello S., 2020, Relationship between Citizens´ Health Engagement and Intention to Take the COVID-19 Vaccine in Italy: A Mediation Analysis. Vaccines (Basel). 8(4), 576.

[16] Pogue K., Jensen J. L., Stancil C. K., Ferguson D. G., Hughes S. J., Mello E. J. et al., 2020, Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States. Vaccines (Basel). 8(4), 582.

[17] Head K. J., Kasting M. L., Sturm L. A., Hartsock J. A., Zimet G. D., 2020, A National Survey Assessing SARSCoV-2 Vaccination Intentions: Implications for Future Public Health Communication Efforts. Science Communication. 42(5), 698-723.

[18] Sherman S. M., Smith L. E., Sim J., Amlôt R., Cutts M., Dasch H. et al., 2021, COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vaccin Immunother. 17 (6), 1612-1621.

[19] Reiter P. L., Pennell M. L., Katz M. L., 2020 Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine. 38(42), 6500-6507.

[20] Biasio L. R., Bonaccorsi G., Lorini C., Pecorelli S., 2021, Assessing COVID-19 vaccine literacy: a preliminary online survey. Hum Vaccin Immunother. 17 (5), 1304-1312.

[21] Eastwood K., Durrheim D. N., Jones A., Butler M., 2010, Acceptance of pandemic (H1N1) 2009 influenza vaccination by the Australian public. Med J Aust. 192 (1): 33-36.

[22] Bruce N., et al., 2008, Quantitative research methods for health research: a practical interactive guide to epidemiology and statistics. Chichester, UK: Wiley

[23] CSPro (2023) Census and Survey Processing System (CSPro) Online Available https://www.census.gov/data/software/cspro.html (Accessed July 2023)

[24] Banik R., Rahman M., Sikder M. T., Rahman Q. M., Pranta M. U. R., 2021, Knowledge, attitudes, and practices related to the COVID-19 pandemic among Bangladeshi youth: a web-based cross-sectional analysis. J Public Health (Bangkok). https://doi.org/10.1007/s10389-020-01432-7.

[25] Hossain M. A., Jahid M. I. K., Hossain K. M. A, Walton L. M., Uddin Z., Haque M. O., et al., 2020, Knowledge, attitudes, and fear of COVID-19 during the rapid rise period in Bangladesh. PLoS One. 15(9), e0239646. https://doi.org/10.1371/journal.pone.0239646

Abstract:

The pediatric HIV burden is significant, with 46% of 1.7 million affected children lacking treatment in 2020. In sub-Saharan Africa, up to 49% of HIV-infected children remain undiagnosed, contributing to high AIDS-related mortality. In Zambia, early infant diagnosis (EID)coverage for HIV-exposed infants (HEI) is suboptimal with  71%  receiving timely virologic testing, indicating gaps in case identification. We explored healthcare workers' perceptions of Early Infant Diagnosis, appointment systems and associated challenges. Respondents were selected in two stages: Firstly, facilities were purposively sampled based on high HIV-Exposed Infants volumes. Secondly, 19 respondents were purposively sampled within the province (1), district (2) and facilities(16)based on their roles within the PMTCT department. All Content and thematic analyses were done using NVivo 10 software. Healthcare providers reported using registers to identify and track HIV-exposed infants’ appointments, leveraging routine immunization visits for identification across the cascade up to 9 months old and utilizing an integrated electronic medical records system (SmartCare) for appointment and service tracking. However, health care providers highlighted challenges that include cumbersome paper-based registers, leading to incomplete documentation and difficulties in tracking HIV-exposed infants’ appointments, Loss to follow-up rises after 9 months, attributed to decreased attendance post-routine immunizations and SmartCare’s dual documentation add to workload, leading to incomplete records, hindering appointment tracking due to time-consuming data entry and lack of critical information. Our study, recommends streamlining appointment systems to cover the entire infancy period, enhancing register design, and providing additional training for electronic medical record systems to healthcare providers to improve efficiency.

References:

[1] Newell, M. L., Coovadia, H., Cortina-Borja, M., Rollins, (2004). Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet, 364, 1236–1243. [PubMed]

[2] Chintu, C., Bhat, G. J., Walker, A. S., Mulenga, V., Sinyinza, et al. (2004). Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomized placebo-controlled trial. Lancet, 364, 1865–1871. [PubMed]

[3] Kabue, M. M., Buck, W. C., Wanless, S. R., Cox, C. M., McCollurg, E. D. (2012). Mortality and clinical outcomes in HIV-infected children on antiretroviral therapy in Malawi, Lesotho, and Swaziland. Pediatrics, 130, e591–e599. [PMC free article] [PubMed]

[4] Brady, M. T., Oleske, J. M., Williams, P. L., Elgie, C., (2010). Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquire Immune Defic Syndr, 53, 86–94. [PMC free article] [PubMed]

[5] World Health Organization. (2010). Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. Geneva, Switzerland: World Health Organization. [PubMed]

[6] The United Nations Children's Fund (UNICEF). (2019). Children, HIV and AIDS. Regional Snapshot: sub-Saharan Africa. UNICEF. Retrieved from https://www.childrenandaids.org/sites/default/files/2020-08/SSA%20Regional%20snapshot-%20v5-%206%20Nov%20%281%29.pdf.

[7] HIV/AIDS Zambia. UNICEF (2021). Retrieved from https://www.unicef.org/zambia/hivaids.

[8] Mutanga, J. N., Mutembo, S., Ezeamama, A. E., et al. (2020). Tracking progress toward elimination of mother to child transmission of HIV in Zambia: findings from the early infant diagnosis of HIV Program (2009–2017). Journal of Tropical Pediatrics, 66(1), 56–65. doi:10.1093/tropej/fmz030. pmid:31089687Top of Form

[9] Modi, S., Callahan, T., Rodrigues, J., Kajoka, M. D., Dale, H. M. (2017). Overcoming Health System Challenges for Women and Children Living with HIV Through the Global Plan. Journal of Acquired Immune Deficiency Syndromes, 75(Suppl 1), S76-S85. doi:10.1097/QAI.0000000000001336

[10]             Ahmed, S., Kim, M. H., Sugandhi, N., Phelps, B. R., Sabelli, R., Diallo, M. O. (2013). Beyond early infant diagnosis: Case finding strategies for identification of HIV-infected infants and children. AIDS, 27(0 2), S235–S245. doi: 10.1097/QAD.0000000000000099

[11] MoH. (2022). Annual Health Statistical Report 2017-2021 (Tracking Performance of the NHSP 2017-2021). P.O BOX 30205 Ndeke House, Lusaka Zambia. Retrieved from www.moh.gov.zm.

[12] Ministry of Health, Zambia. (2017). Zambia National Health Strategic Plan 2017 – 2021. Retrieved from https://www.moh.gov.zm/.

[13] Mosaddegh, A.M. (2014). Factors influencing healthcare service quality. International Journal of Health Policy and Management, 3(2), 77-89. DOI: 10.15171/ijhpm.2014.65. PMID: 25114946; PMCID: PMC4122083.

[14] Odekunle, F.F., Adekunle, R.O., & Shankar, S. (2017). Why sub-Saharan Africa lags in electronic health record adoption and possible strategies to increase its adoption in this region. International Journal of Health Sciences, 11, 59-64. [PMC free article] [PubMed]

[15] Gumede-Moyo, S., Todd, J., Bond, V., Mee, P., & Filteau, S. (2019). A qualitative inquiry into implementing an electronic health record system (SmartCare) for prevention of mother-to-child transmission data in Zambia: a retrospective study. BMJ Open, 9(9), e030428. doi: 10.1136/bmjopen-2019-030428.

[16] Simbaya, J., Funjika, P., Moonga, A., Mwale, J., & Kankasa, C. (2021). Feasibility of using infant testing during immunization to estimate HIV mother-to-child transmission rates in Zambia. BMC Infectious Diseases, 21(1), 1239. doi: 10.1186/s12879-021-06892-0. [PMID: 34886792; PMCID: PMC8655713]

[17] Dunning, L., Gandhi, A. R., Penazzato, M., Soeteman, D. I., Revill, P., Frank, (2021). Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: A cost-effectiveness analysis. Journal of the International AIDS Society, 24(1), e25651. https://doi.org/10.1002/jia2.25651

[18] Douglas, G. P., Gadabu, O. J., Joukes, S., et al. (2010). Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi. PLoS Med, 7, e1000319. https://doi.org/10.1371

[19] Abiy, R., Gashu, K., Asemaw, T., et al. (2018). A comparison of electronic records to paper records in antiretroviral therapy clinic in Ethiopia: what is affecting the quality of the data? Online Journal of Public Health Informatics, 10, e212. doi: 10.5210/ojphi.v10i2.8309.

[20] ICAP. (2023). ICAP in Zambia supports improved HIV care and prevention of mother-to-child transmission. Retrieved from https://icap.columbia.edu/news-events/icap-in-zambia-supports-improved-hiv-care-and-prevention-of-mother-to-child-transmission/.

[21] Finocchario-Kessler S, Brown M, Maloba M, Nazir N, Wexler C, Goggin K, D., et al (2021). A Pilot Study to Evaluate the Impact of the HIV Infant Tracking System (HIT System 2.0) on Priority Prevention of Mother-to-Child Transmission (PMTCT) Outcomes. AIDS Behav, 25(8), 2419-2429. Doi: 10.1007/s10461-021-03204-0.

[22] Mate, K. S., Bennett, B., Phase, W., Barker, P., & Rollins, N., et al (2009). Challenges for routine health system data management in a large public program to prevent mother-to-child HIV transmission in South Africa. PLoS One, 4, e5483.

[23] Tembo, T., Dale, H., Muttau, N., Itoh, M., Williamson, D., Mwamba, C., Herce, M. E., et al (2022). "Testing Can Be Done Anywhere”: A Qualitative Assessment of Targeted Community-Based Point-of-Care Early Infant Diagnosis of HIV in Lusaka, Zambia. Global Health: Science and Practice, 10(3), e2100723. https://doi.org/10.9745/GHSP-D-21-00723

[24] Ministry of Health, Zambia. (2022). Zambia consolidated guidelines for treatment and prevention of HIV infection. Retrieved from https://www.differentiatedservicedelivery.org/wp-content/uploads/August-2022-Zambia-Consolidated-Guidelines.pdf

Abstract:

The emergence and spread of zoonotic diseases pose significant threats to public health, animal health, and global health security. In Cameroon (a country situated at the Central and West Africa intersection and known for its rich biodiversity and close interactions between humans and animals), priority zoonoses represent a major public health concern. This paper examines the diagnostic landscape for priority zoonoses in Cameroon, focusing on the challenges and opportunities for disease detection and control. This study assessed the current state of diagnostic capacity for key zoonotic diseases in the country through a comprehensive review of existing literature, national surveillance data, and expert interviews. The analysis highlights several challenges, including limited laboratory infrastructure, inadequate funding, gaps in surveillance systems, and a lack of trained personnel. However, the study also identified promising opportunities for strengthening the diagnostic landscape such as enhanced collaboration between human and animal health sectors, improved access to diagnostic tools, and increased investment in capacity building. By addressing these challenges and capitalizing on the available opportunities, Cameroon can better prepare for and respond to priority zoonotic disease outbreaks, ultimately safeguarding the health of both humans and animals in the country.

References:

[1].   Centres for Disease Control and Prevention (2024). Zoonotic Diseases. Retrieved from: https://www.cdc.gov/onehealth/basics/zoonotic-diseases.html#:~:text=Zoonotic%20diseases%20are%20caused%20by,serious%20illness%20and%20even%20death.

[2].   World Organisation for Animal Health. (2024). World Organisation for Animal Health (WOAH, founded as OIE). Retrieved from: https://food.ec.europa.eu/horizontal-topics/international-affairs/international-standards/woah_en#:~:text=WOAH%20is%20an%20intergovernmental%20organisation,currently%20has%20182%20member%20countries.

[3].   One Health Cameroon. (2024). Zoonotic Diseases in Cameroon. Retrieved from: https://www.onehealth.cm/web/index.php/fr/about/zoonotic-diseases.

[4].   The World Fact Book. (2016). Central Intelligence Agency. Cameroon. Retrieved from: https://www.cia.gov/the-world-factbook/countries/cameroon/

[5].   Ngapagna, A. N., et al. (2023). Analysis of Cameroonian Veterinary Health Legislation for the Control of Priority Zoonoses in Relation to the OIE/WOAH Guidelines with Regard to the One Health Approach. J Vet Sci Res. 2023, 8(1): 000234.

[6].   Bhatia, D., Sohini, P., Acharjee, T., & Ramachair, S. S (2024). Biosensors and their Widespread Impact on Human Health. Sensors International: 5, 100257. Doi: https://doi.org/10.1016/j.sintl.2023.100257.

[7].   One Health Cameroon (2021). Landscape Analysis on Priority Zoonotic Diseases in Cameroon: Retrieved from: https://onehealthbehaviors.org/wp-content/uploads/2022/09/LANDSCAPE-ANALYSIS-ON-PRIORITY-ZOONOTIC-DISEASES-CAMEROON-2021JUL29.pdf

[8].   Aborode, A. T., Hasan M. M., Jain, S., Okereke, M., Adedeji, O. J ., Karra-Aly, A., Fasawe, A. S. (2021). Impact of Poor Disease Surveillance System on COVID-19 Response in Africa: Time to Rethink and Rebuilt. Clin Epidemiol Glob Health. 12, 100841. Doi: 10.1016/j.cegh.2021.100841.

[9].   Eko, S. M., Esemu, S. N., Njouendou, A. J., Kfusi, A. J., Anong, N. D., Ndip, L. M., (2023). Identification and Prevalence of Brucella Species Circulating among Cattle Slaughtered in the Douala and Buea Municipalities of Cameroon”, Veterinary Medicine International, 2068948. Doi: https://doi.org/10.1155/2023/2068948

[10].  Tahmo,  N. B., Wirsiy,  F. S., Nnamdi,  D. B., Tongo, M., Lawler, J. V., Broadhurst,  M. J., Wondji, C. S., Brett-Major, D. M., (2023). An Epidemiological Synthesis of Emerging and Re-Emerging Zoonotic Disease Threats in Cameroon, 2000–2022: A Systematic Review. IJID Reg. 7, 84–109. Doi: 10.1016/j.ijregi.2022.12.001.

[11].  United Nations, Department of Economic and Social Affairs. (2023). Population of Cameroon (2023 and historical). Retrieved from: https://www.worldometers.info/world-population/cameroon-population/

[12].  Wade, A., and Kamdjo, G. (2019). Investigation into The First Anthrax Outbreak in A Cattle Farm in West Cameroon. Biomed J Sci & Tech Res. Doi: 10.26717/BJSTR.2019.16.002784.

[13].  One Health Cameroon. (2023). Zoonotic Diseases in Cameroon. Retrieved from: https://www.onehealth.cm/web/index.php/fr/about/zoonotic-diseases.

[14].  Kouam, M. K., Tchouankui, H. N., and Ngapagna, A. N. (2019). Epidemiological Features of Highly Pathogenic Avian Influenza in Cameroon, Veterinary Medicine International, 3796369. Doi: https://doi.org/10.1155/2019/3796369

[15].  International Federation of Red Cross And Red Crescent Societies. (2022). Cameroon: Cholera and Monkeypox outbreak, 2022 Situation Report. Retrieved from: https://reliefweb.int/report/cameroon/cameroon-cholera-and-monkeypox-outbreak-dref-application-mdrcm032

[16].  Ministry of Public Health (2022). Cameroon National Laboratory Policy. Retrieved from: https://files.aho.afro.who.int/afahobckpcontainer/production/files/CAMEROON-NATIONAL-LABORATORY-POLICY_compressed_1.pdf

[17].  Kadia, R. S. M., Kadia, B. M., Dimala, C. A. et al. (2023). Usefulness of Disease Surveillance Data in Early Warning of the Cholera Outbreak in Southwest Cameroon, 2018. Confl Health 17,6. Doi: https://doi.org/10.1186/s13031-023-00504-1

[18].  Larkins, M. C., & Thombare A. (2024). Point-of-Care Testing. StatPearls Publishing; 012024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK592387/

[19].  World Health Organization. (2018). Primary Health Care and Health Emergencies. Available at: https://www.researchgate.net/publication/336349039_World_Health_Organization_2018_Primary_health_care_and_health_emergencies

[20].  Kunda, J., Kazwala, R., Mfinanga, G. S., (2008). Knowledge of Causes, Clinical Features and Diagnosis of Common Zoonoses Among Medical Practitioners in Tanzania. BMC Infect Dis. 12 2;8:162. Doi: 10.1186/1471-2334-8-162. PMID: 19046464; PMCID: PMC2611996.

[21].  Kibu O. (2018). Health Surveillance System: Alert and Response Capacity of Cameroon. Retrieved from: https://nkafu.org/wp-content/uploads/2019/02/Health-surveillance-system-in-camer.pdf

[22].  World Health Organization. (2024a). Surveillance in emergencies. Retrieved from: https://www.who.int/emergencies/surveillance#:~:text=Surveillance%20in%20emergencies&text=Public%20health%20surveillance%20is%20the,interpretation%20of%20health%2Drelated%20data.

[23].  Sofeu, C. L., Broban, A., Njifou Njimah, A., Blaise, M. J., Sadeuh-Mba, S. A., Druelles, S., L’Azou, M., Tejiokem, M. C. (2018). Improving Systematic Rabies Surveillance in Cameroon: A Pilot Initiative and Results for 2014-2016. PLoS Neglected Tropical Diseases, 6;12(9):e0006597. Doi: https://doi.org/10.1371/journal.pntd.0006597

[24].  Djuikoue C. I., Toutcho C. N., Savadogo, M. et al. (2023). Awareness of Rabies Control and Challenges to the Intersectoral Management of Dog Bites in Western Cameroon, Research Square. Doi: https://doi.org/10.21203/rs.3.rs-2820317/v1

[25].  World Health Organisation (2024b): Neglected Tropical Diseases. Retrieved from: https://www.who.int/health-topics/neglected-tropical-diseases#tab=tab_1

[26].  Drugs for Neglected Diseases Initiative (2024). Neglected Tropical Diseases. A Global Emergency. Available at: https://dndi.org/diseases/neglected-tropical-diseases/?gad_source=1&gclid=Cj0KCQjw_-GxBhC1ARIsADGgDjuAQELphYfMvwtkqRk1U5oI5l8bU7OHt9ooMFQbDFL_6mey0U_28vAaAo6KEALw_wcB.

[27].  World Health Organisation (2022a): Benin, Uganda and Rwanda Eliminate Human African Trypanosomiasis as a Public Health Problem> Retrieved from: https://www.who.int/news/item/24-05-2022-benin--uganda-and-rwanda-eliminate-human-african-trypanosomiasis-as-a-public-health-problem

[28].  United States Department of Agriculture (2012). Meeting Critical Laboratory Needs for Animal Agriculture: Examination of Three Options. National Academies of Sciences, Engineering, and Medicine. Doi: https://doi.org/10.17226/13454.

[29].  World Health Organisation (2022b): Lassa Fever – Nigeria. Retrieved from: https://www.who.int/emergencies/disease-outbreak-news/item/lassa-fever---nigeria

[30].  Zhang, L., Guo, W., & Lv, C. (2024). Modern Technologies and Solutions to Enhance Surveillance and Response Systems For Emerging Zoonotic Diseases. Science in One Health 3,100061. Doi: https://doi.org/10.1016/j.soh.2023.100061

Abstract:

This study aims to examine the knowledge, perception and preference of family planning methods among women of the Christian faith with a particular focus on women from 3 different congregations within the Christian faith. A cross-sectional Descriptive survey was deployed as a design. A structured questionnaire was the instrument used and a total of 315 respondents were all women and attended: The Redeemed Christian Church of God, Palace of Grace Parish, Iju, Lagos, The City of the Lord Church, Beautiful Gate Solution, Giwa, Oke Aro, Ogun State, and The Celestial Church of Christ, Oluwatosin Parish, Iju, Lagos, Nigeria filled and returned their questionnaires. Data collected was analyzed with the aid of descriptive statistics of frequency, tables and percentages. Findings from the study revealed that the majority of the women ((86.0%) have substantial knowledge about contraceptives and their perception was affirmative. Also, the study was able to establish that the commonly used method was hormonal contraception implants (63.3%). A major determinant of the choice of contraceptives was the health benefits and couples’ convenience. This study highly recommends the sustenance of the intensity of campaign, advocacy and awareness creation on the usefulness and health benefits of appropriate usage of family planning methods. It is also recommended that the involvement of men in the reproductive health of every woman, especially in family planning will further enhance women's involvement and improve their attitudes positively.

References:

Abstract:

The escalating ubiquity of heart abnormality extensively, coupled with a multistorey mortality rate, underscores the crucial need for instantaneous and efficacious characteristic measures. Recognizing the censorious nature of this health concern, there's an increasing ultimatum for procedure and machine techniques that can expeditiously and exactly associate these ailments. The reason is to plan a mechanized technique category irregular beat sound prompt to help the surgeon. To the leading of our information, often primary analysis about that employment a single neural organize show sort of 8 diverse sorts of pulse sound signal. In an electrocardiogram (ECG), the electrical action of the heart is recorded and usually spoken to graphically as an arrangement of waves. The ordinary frequency range for an ECG signal is within the run of 0.05 to 150 Hz. The low-frequency components of the ECG signal (0.05 to 1 Hz) constitute the pattern or the slow-changing components of the heart's electrical action. The high-frequency components (1 to 150 Hz) capture the fast changes related to the depolarization and repolarization of the heart's chambers. The recommended show is collated with CNN multilayer perceptron (MLP) in diverse execution assessment lattices. Besides, the results of machine learning (ML) models are moreover examined. Scheduled show accomplished increases classification acc. (multiple layers with dropout) acc. 99.35 (single layer with drop) acc. 98.69 (single layer with no drop) acc. 98.18 (multiple layers with no drop) acc. 99.04 dispute collection of data, which is reliably predominant to its contestant approaches. Representation distributes vital advice to the vascular specialist identifying heart spout ailment.

References:

[1] Shivnarayan Patidar, Ram Bilas Pachori, 2014, Classification of Cardiac Sound Signals Using Constrained Tunable-Q Wavelet Transform”, Expert Systems with Applications, Volume 41, Issue 16, 7161-7170, https://doi.org/10.1016/j.eswa.2014.05.052

[2] Manab K., Das corresponding author and Samit Ari, 2014 , Patient-specific ECG Beat Classification Technique, National Library of Medicine, Doi: 10.1049/htl.2014.0072, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611171/

[3] lvarado, A. S., Lakshminarayan, C., Principe, J. C, 2012, Time-Based Compression and Classification of Heartbeats, IEEE Transactions on Biomedical Engineering 59, 1641–1648, Doi: 10.1109/TBME.2013.2238191, https://ieeexplore.ieee.org/document/6409262?denied=

[4] de Chazal, P., Reilly, R. B, 2006, A Patient-Adapting Heartbeat Classifier Using ECG Morphology and Heartbeat Interval Features, IEEE Transactions on Biomedical Engineering 53, 2535–2543, Doi: 10.1109/TBME.2006.883802, https://ieeexplore.ieee.org/document/4015601

[5] Christov, I., Jekova, I., Bortolan, G, 2005, Premature Ventricular Contraction Classification by the k^th Nearest-Neighbours Rule, Physiological Measurement 26, 123, Doi: 10.1088/0967-3334/26/1/011, https://iopscience.iop.org/article/10.1088/0967-3334/26/1/011/meta

[6] Hassaan Malik, Umair Bashir, Adnan Ahmad, 2022, Multi-Classification Neural Network Model for Detection of Abnormal Heartbeat Audio signal, Volume 4, 100048, https://doi.org/10.1016/j.bea.2022.100048

[7] Velagapudi Swapna Sindhu, Kavuri Jaya Lakshmi, Ameya Sanjanita Tangellamudi, K. Ghousiya Begum, 2023, A Novel Deep Neural Network Heartbeats Classifier for Heart Health Monitoring, Volume 4, 1-10, https://doi.org/10.1016/j.ijin.2022.11.001

[8] Omair Rashed Abdulwareth Almanifi, Ahmad Fakhri Ab Nasir, Mohd Azraai Mohd Razman, Rabiu Muazu Musa, Anwar, P. P., AbdulMajeed, 2022, Heartbeat Murmurs Detection in Phonocardiogram Recordings via Transfer Learning, Journal 61, 10995–11002, https://doi.org/10.1016/j.aej.2022.04.031

[9] Pratik Kanania, Mamta Padoleb, 2020, ECG Heartbeat Arrhythmia Classification using Time-Series Augmented Signals and Deep Learning Approach, Procedia Computer Science 171, 524–531, https://doi.org/10.1016/j.procs.2020.04.056

[10] Manish Sharma, Ru-San Tan, U. Rajendra Acharya, 2019, Automated Heartbeat Classification and Detection of Arrhythmia using Optimal Orthogonal Wavelet Filters, Informatics in Medicine Unlocked 16, 100221, https://doi.org/10.1016/j.imu.2019.100221

[11] Aashay Gondalia a, Dhruv Dixit b, Shubham Parashar c, Vijayanand Raghava d, Animesh Sengupta e, Vergin Raja Sarobin, 2018, IoT-based Healthcare Monitoring System for War Soldiers using Machine Learning, Procedia Computer Science, Volume 133, 1005-1013, https://doi.org/10.1016/j.procs.2018.07.075

[12] Edward, B., Panganiban, a., Arnold, C., Paglinawan, b., Wen Yaw Chung c., Gilbert Lance S., Paa, d., 2021, ECG Diagnostic Support System (EDSS): A Deep Learning Neural Network Based Classification System for Detecting ECG Abnormal Rhythms from a Low-Powered Wearable Biosensors, Sensing and Bio-Sensing Research, Volume 31, 100398, https://doi.org/10.1016/j.sbsr.2021.100398

[13] Jonas Chromik, Lukas Pirl, Jossekin Beilharz, Bert Arnrich, Andreas Polze, 2021, Certainty in QRS Detection with Artificial Neural Networks, IEEE Conference, Volume 68, 102628, https://doi.org/10.1016/j.bspc.2021.102628

[14] Zhongwei Jiang, Samjin Choi, 2006, A Cardiac Sound Characteristic Waveform Method for in-home Heart Disorder Monitoring with Electric Stethoscopes, Volume 31, Issue 2, 286-298, https://doi.org/10.1016/j.eswa.2005.09.02510

[15] D. Kumar, P. Carvalho, M. Antunes, P. Gil, J. Henriques, L. Eugenio, 2006, A New Algorithm for Detection of S1 and S2 Heart Sounds”, IEEE Conference, DOI:10.1109/ICASSP.1660559, https://www.semanticscholar.org/paper/A-New-Algorithm-for-Detection-of-S1-and-S2-Heart-Kumar-Carvalho/120916432fa36d0c2c0d1d1a685a682eae42080d

[16] De Lannoy, G., Francois, D., Delbeke, J., Verleysen, M, 2012, Weighted Conditional Random Fields for Supervised Interpatient Heartbeat Classification, IEEE Transactions on Biomedical Engineering, Doi: 10.1109/TBME.2011.2171037, https://pubmed.ncbi.nlm.nih.gov/21990327/

[17] Guler, I., Ubeylı, E. D, 2005, ECG Beat Classifier Designed by Combined Neural Network Model, Pattern Recognition 38(2):199-208, Doi:10.1016/S0031-3203(04)00276-6, https://www.researchgate.net/publication/271584317_ECG_beat_classifier_designed_by_combined_neural_network_model

[18] Das, M. K., Ari, S., 2014, Patient-Specific ECG Beat Classification Technique, Healthcare Technology Letters, PMID: 26609386 PMCID: PMC4611171 DOI: 10.1049/htl.2014.0072 https://pubmed.ncbi.nlm.nih.gov/26609386/

[19] Hu, Y. H., Palreddy, S., Tompkins, W. J, 1997, A Patient-Adaptable ECG Beat Classifier Using A Mixture of Experts Approach, IEEE Transactions on Biomedical Engineering 44, 891–900, DOI 10.1109/10.623058, https://ieeexplore.ieee.org/document/623058

[20] Huang, H., Liu, J., Zhu, Q., Wang, R., Hu, G, 2014, Detection of Inter-Patient Left and Right Bundle Branch Block Heartbeats in ECG using Ensemble Classifiers, Biomedical Engineering Online 13, 72, https://doi.org/10.1186/1475-925X-13-72

[21] Huang, H., Liu, J., Zhu, Q., Wang, R., Hu, G., 2014, A New Hierarchical Method for Inter-Patient Heartbeat Classification using Random Projections and rr intervals, Biomedical Engineering Online 13, 90, https://doi.org/10.1186/1475-925X-13-90

[22] Ince, T., Kiranyaz, S., Gabbouj, M., 2009, A Generic and Robust System for Automated Patient-Specific Classification of ECG signals, IEEE Transactions on Biomedical Engineering 56, 1415–1426, DOI: 10.1109/TBME.2009.2013934, https://ieeexplore.ieee.org/document/4776456

[23] Jacobs, R. A., 1995, Methods for Combining Experts’ Probability Assessments”, Neural Computation 7, 867–888, https://direct.mit.edu/neco/article-abstract/7/5/867/5891/Methods-For-Combining-Experts-Probability?redirectedFrom=fulltext

[24] Liao, T. W., 2005, Clustering of Time Series Data—A Survey, Pattern Recognition 38, 1857–1874, https://doi.org/10.1016/j.patcog.2005.01.025

[25] Llamedo, M., Mart ́ınez, J. P., 2011, Heartbeat Classification Using Feature Selection Driven by Database Generalization Criteria, IEEE Transactions on Biomedical Engineering 58, 616–625.DOI: 10.1109/TBME.2010.2068048, https://ieeexplore.ieee.org/document/5551181

[26] Salem, A. B. M., Revett, K., El-Dahshan, E., 2009. Machine Learning in Electrocardiogram Diagnosis. International Multiconference on Computer Science and Information Technology, https://www.proceedings2009.imcsit.org/pliks/10.pdf

Abstract:

Globally, the most common cancer to be diagnosed in women is breast cancer, surpassing lung cancer. One of the treatments used is carboplatin, which is a platinum-based drug. These substances function by preventing the growth of cancerous cells. We conducted a study to evaluate the dosage dependency of carboplatin in light of the adverse effects that have been recorded in patients. After being cultivated, the MTT test was used to determine the vitality of the MCF-7 breast cancer cell line. Afterwards, cDNA synthesis was carried out after RNA isolation using the TRIzol technique. Finally, a quantitative real-time polymerase chain reaction was used to analyze gene expression. Every single result was statistically examined using SPSS. The results demonstrated that MCF-7 cell lines multiplied both before and following carboplatin therapy. Furthermore, they showed that the STAT3 gene was expressed in MCF-7 both before and during the carboplatin treatment. According to our research, if carboplatin is taken at the lowest risk dosage, it can be very beneficial in treating breast cancer. However, since this is just an early study, more investigation and pre-clinical approval are required.

References:

[1] Ye, F., Dewanjee, S., Li, Y., Jha, N. K., Chen, Z. S., Kumar, A., et al., Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Mol Cancer. 2023 Jul 6;22(1):105.

[2] Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022 Dec;66:15–23.

[3] Pillai, D., Narayan, J., Gentry-Maharaj, A., Deo, S., Vijaykumar, D. K., Mukherjee, P., et al., Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India. Cancers (Basel). 2023 May 30;15(11):2973.

[4] Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., et al., Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018 Jun;5(2):77–106.

[5] Yang, F., He, Q., Dai, X., Zhang, X., Song, D., The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies. Front Pharmacol. 2023 Feb 22;14.

[6] McCrudden, C. M., McCarthy, H. O., Current status of gene therapy for breast cancer: progress and challenges. Appl Clin Genet. 2014;7:209–20.

[7] Ibnat, N., Chowdhury, E. H., Retarding breast tumor growth with nanoparticle-facilitated intravenous delivery of BRCA1 and BRCA2 tumor suppressor genes. Sci Rep. 2023 Jan 11;13(1):536.

[8] Karjoo, Z., Chen, X., Hatefi, A., Progress and problems with the use of suicide genes for targeted cancer therapy. Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):113–28.

[9] Mehrotra, R., Yadav, K., Breast cancer in India: Present scenario and the challenges ahead. World J Clin Oncol. 2022 Mar 24;13(3):209–18.

[10] Javanbakht, M., Tahmasebzadeh, S., Cegolon, L., Gholami, N., Kashaki, M., Nikoueinejad, H., et al., Oncolytic viruses: A novel treatment strategy for breast cancer. Genes Dis. 2023 Mar;10(2):430–46.

[11] Schmidt, M., Heimes, A. S., Immunomodulating Therapies in Breast Cancer—From Prognosis to Clinical Practice. Cancers (Basel). 2021 Sep 29;13(19):4883.

[12] Mustafa, G., Hassan, D., Ruiz-Pulido, G., Pourmadadi, M., Eshaghi, M. M., Behzadmehr, R., et al. Nanoscale drug delivery systems for cancer therapy using paclitaxel— A review of challenges and latest progressions. J Drug Deliv Sci Technol. 2023 Jun;84:104494.

[13] Dasari, S., Bernard Tchounwou, P., Cisplatin in cancer therapy: Molecular mechanisms of action. Eur J Pharmacol. 2014 Oct;740:364–78.

[14] Loh, C. Y., Arya, A., Naema, A. F., Wong, W. F., Sethi, G., Looi, C. Y., Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication. Front Oncol. 2019 Feb 21;9.

[15] Tolomeo, M., Cascio, A., The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy. Int J Mol Sci. 2021 Jan 9;22(2):603.

[16] Carpenter, R., Lo, H. W., STAT3 Target Genes Relevant to Human Cancers. Cancers (Basel). 2014 Apr 16;6(2):897–925.

[17] Yu, K. D., Ye, F. G., He, M., Fan, L., Ma, D., Mo, M., et al. Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer. JAMA Oncol. 2020 Sep 1;6(9):1390.

[18] Perez, E. A., Carboplatin in Combination Therapy for Metastatic Breast Cancer. Oncologist. 2004 Sep 1;9(5):518–27.